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CHAPTER I 
INTRODUCTION 
The essential problem of malignancy is associated with the nature 
of the disturbance which leads to the purposeless multiplication and 
spread of cells in the body of the afflicted individual. 
Before overt manifestations of malignancy - cancer or leukaemia 
- are discernable, a whole series of events takes place some of which 
can be investigated either clinically or experimentally. The most in-
teresting objects of current research are the identification of a causa-
tive agent and the kinetics of the proliferation of the transformed 
cells at the expense of the normal cells of the body. The knowledge 
gathered from these investigations will hopefully provide a basis for 
the institution of a therapy which results in lasting remissions while 
avoiding the damage of normal cells such as occurs with the present 
forms of treatment. 
I. Malignant transformation 
"Transformation" of cells has been originally defined as a change 
in morphology and growth pattern of cultured cells in vitro caused 
by the transforming agent, e.g. a virus. In the living organism cells 
which have been transformed to malignant cells do not always dis-
play these features as distinctively as in tissue culture and the defini-
tion could be modified to: the change resulting in the capacity of 
cells to proliferate under environmental conditions in which normal 
cells do not. 
Transformed cells in vitro often have altered nutritional require-
ments. Deviation from normal metabolism is demonstrated in several 
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types of cancer cells and has led to numerous theories on the nature 
of malignancy. The great interest displayed from the dawn of cancer 
research in pin-pointing the essential metabolic deviation and using 
this as a base for a potentially selective attack, is understandable. The 
efforts to reveal differences in metabolism between normal and 
malignant cells and to apply these to therapy have been largely un-
rewarding, but this approach recently proved fruitful as demon-
strated by the usefulness of L-asparaginase in certain clinical cases of 
lymphoma and acute lymphoblastic leukaemia (Crowther 1971 ). 
However, it has not thrown much light on the cause of malignant 
transformation. 
Smithers (1962) warned against spending too much energy in the 
cytological approach to cancer and compared this type of approach 
to trying to solve our traffic problems by studying the internal-
combustion engine. He preferred to call cancer a disease of organi-
sation. The mechanism underlying the autonomy of malignant cells 
should therefore not only be sought within the cells themselves but 
also in local factors and in regulatory systems of the body. On the 
other hand, it is a matter of dispute whether autonomy is an essential 
feature of malignancy. Endocrine tumours often remain partially de-
pendent on hormonal stimulation, although their neoplastic nature 
seems beyond doubt. 
A related aspect of malignancy is transplantability, which enables 
the cells to multiply at places distant from their origin, because they 
proliferate independently from the contribution of cells from a pre-
cursor compartment. This can be either within the body in which the 
neoplasia originated or, after transplantation, in another individual. 
However, the propagation of malignant growth by the transfer of one 
single or a small number of cells is not always successful. As malig-
nantly transformed cells may exhibit new "transplantation"-antigens 
which can elicit an immune reaction, sometimes even in the primary 
host, the milieu can be prohibitive for the growth of these cells. The 
failure to demonstrate transplantability therefore does not disprove 
malignancy. 
Most virus-induced neoplasms, the malignancy of which is uncon-
tested, are not transplantable. Apart from immunological defense 
mechanisms other factors are involved as well. 
The regulatory mechanisms of the living organism being absent in 
vitro, the irregular growth pattern of transformed cells observed in 
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tissue cultures must be attributed to defective cell-to-cell interrela-
tions which normally are mediated either by humoral substances or 
by mechanical contact. 
The importance of the structure of the membrane for the phe-
nomenon of contact inhibition was recently revealed by the dis-
covery of the adherence of concanavalin A, an agglutinin isolated 
from jack bean meal, to the surface of transformed fibroblasts, and 
the consequent reversal of the growth pattern to normal (Burger e. a. 
1970). Apparently, the contact inhibition of division depends on the 
molecular configuration of certain parts of the cell membrane. This 
view has been substantiated by the exposure of agglutinin receptor 
sites on the surface of normal cells by treatment with proteolytic 
enzymes which resulted in a transient escape from growth control 
(Sefton and Rubin 1970, Burger 1970b ). Trypsin treated normal 
cells, however, did not give rise to tumours in vivo (In bar e.a. 1972). 
The results of the application of concanavalin A and related sub-
stances in vivo are regarded with interest. Although it is unlikely that 
the membrane alterations are the only factor responsible for the pro-
liferative derangement of cancer cells, the manipulation of cell con-
tact can be expected to give insight in the relative importance of this 
and of other factors. 
The proliferation of malignant cells in vivo gives the impression of 
being unregulated and unrestrained. The mitotic activity of the cells 
seems to be set at a constant level, irrespective of the need. Some-
times it is greater than normal but often it is lower (Baserga 1965), 
and due to the longevity of the progeny there is an increase in the 
number of cells which do not confine themselves to natural bounda-
ries but invade the structures beyond, hamper other cells and damage 
tissues by pressure or interference with blood or nerve supply. How-
ever, ignoring the hormone dependant neoplasias, in many instances 
the proliferative activity of tumour cells appears to be correlated 
with population density: the larger the tumour, the lower the fre-
quency of cell devision (Laird, 1965). In blastic leukaemia substan-
tial differences in mitotic activity have been found according to the 
phase of the disease (Clarckson e.a. 1970). The often observed rise in 
mitotic index and in labeling index after chemotherapy has been as-
sociated with the decrease in population density in the bone marrow 
(ibid.). It is unknown as to how far this phenomenon is influenced 
by contact inhibition or by the availability of nutrients or by other 
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factors. In untreated disease, the paradoxical situation occurs in 
which the least mitotic activity is observed in the most advanced and 
widespread cancer. Both in leukaemia and in solid tumours the ac-
cretion of the cell mass in advanced cases is due to the proliferation 
of a minority of cells (Hauschka 1953). The long life span of their 
progeny results in an accumulation of cells. 
The altered ratio of cell birth and cell death causes a clinically 
detectable tumour to increase in size. This has important consequen-
ces especially for the evaluation of the efficacy of therapy (Bagshawe 
1968). 
Apart from the "anti-social" behaviour of cancer cells a shift to 
the prevalence of immature cells within the malignant cell population 
can be observed. This so-called "dedifferentiation" of solid tumours 
- comparable to the accumulation of blast cells in leukaemia - sug-
gests a maturation defect. Although the development of some types 
of cancer and leukaemia could be explained by a maturation block as 
the primary expression of malignant transformation this block ap-
pears not to be an essential attribute of malignancy. Furthermore, in 
many cases it is not irreversible (Pierce e.a. 1971 ). 
For a unifying concept of cancer all the above-mentioned features 
of malignancy have to be reduced to the same denominator. The cur-
rent concept of molecular biology offers the possibility to conceive 
malignancy either as a consequence of structural derangements of the 
DNA-chain in the cell nucleus (mutation theory) or as a defective or 
aberrant programming of gene function (epigenetic theory). The 
DNA-chain constitutes the template for the various RNA molecules 
participating in the production of proteins and enzymes which char-
acterise the tumour metabolically. Presumably, the DNA-chain is also 
responsible for the transmission of malignant properties of tumour 
cells to their daughter cells. 
At present, the effect of the various carcinogenic agents are 
sought in changes of the genome of the cell. Of the three well-known 
groups of carcinogens - chemicals, radiation and virus - the latter 
presently enjoys the strongest claim as being directly involved in 
malignant transformation. 
Arguments for this theory are: 
I) the isolation of infective virus particles from spontaneous animal 
tumours; 
2) the fact that for tumour induction often only one dose of virus is 
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sufficient; 
3) the short incubation period after virus inoculation in comparison 
with the usually very long latent period after application of radia-
tion or chemicals; 
4) the facility to induce malignant transformation in vitro with 
oncogenic virus; 
5) the isolation of infective virus particles from radiation-induced or 
chemically induced tumours, suggesting the unmasking of latent 
virus. 
Furthermore, in an increasing number of animal neoplasms virus 
particles or virus antigens are being encountered. There is also an ever 
increasing list of publications describing the electron microscopic dis-
covery of virus particles even in human cancer. However, in many of 
these cases the observed structures have later been recognized as cel-
lular organelles and not as virus; in other well decomented cases, 
evidence for a causative relationship remains lacking. 
Hitherto it has been impossible to prove the infectious role of the 
virus particles isolated from malignant human tumours. This does not 
rule out the virus as oncogenic factor in human pathology because it 
is known that a virus can be hidden in the tumour it had induced as 
was demonstrated by the classical example of the Shope-papilloma 
virus: cell free extracts of the papillomas of the feral cotton-tail 
rabbit give rise to fast growing tumours in rabbits. These tumours do 
not contain free virus and extracts of it are not infective. Only by 
serological techniques can the presence of the virus be demonstrated. 
Recent progress in the elaboration of sophisticated methods to 
rescue such so-called defective virus from tissues will undoubtedly 
enlarge the list of viral malignancies, possibly also in man. 
The only human malignancy for which there was until recently 
strong evidence for a viral etiology is Burkitt's lymphoma, but now 
indications of a similar aetiology are accumulating for other tumours 
also. 
Recently Moore e.a. ( 1971) isolated virus particles from human 
milk of different groups of lactating women. They found a correla-
tion betwe.en the incidence of virus and the history of breast cancer 
in the populations studied. The resemblance to the aetiological factor 
of murine mammary carcinoma, the so-called "milk-factor" (Bittner 
1936), later identified as a virus and morphologically similar to the 
human virus, is a striking one and "makes one believe that the 
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isolated virus may well prove to be the causative agent of human 
breast cancer" (Edit. Nature '71 ). 
Although in later studies the authors have been compelled to 
change the morphological classification of the virus particles and to 
withdraw their finding of a difference in incidence of virus in 
patients with and without a family history of breast cancer, the 
evidence of a viral genesis of human breast tumours has not been 
refuted (Sarkar and Moore 1972). 
The fact that cancer and leukaemia apparently do not have an 
epidemic distribution is no argument against the viral aetiology in 
view of what is known of other viral diseases in man, e.g. herpes. 
Obviously other factors play a decisive role in the outbreak of the 
disease. In experimental animals genetic susceptibility, age, sex, co-
carcinogens, etc. play a role in the induction of tumours. Evidence 
for the multi-factorial etiology of human leukaemia has been pre-
sented by Gunz (1970). 
According to the type of nucleic acid they contain, viruses can be 
divided in two categories: DNA- and RNA-viruses. Both categories 
have their representatives in the group of oncogenic viruses. As to be 
expected each type of oncogenic virus has its own way of converting 
normal to neoplastic cells. After penetration into the cell nucleus a 
DNA-virus can presumably insert itself in the DNA-chain of the host. 
After this, one of two events may occur, either production of virus, 
leading to the death of the cell, or transformation of the cell into a 
potentially malignant state. It has been shown for the SV-40 virus 
that at least one and probably several cell devisions are required for 
transformation (Todaro and Green 1966, Sachs 1965). The resulting 
changes will in principle be irreversible and transmitted from cell to 
daughter cells and indistinguishable from the alterations in the 
genome that one is accustomed to call mutations. In rare instances 
reversion of concomittant cell surface changes and cellular behaviour 
has been observed (Rabinowitz and Sachs, 1970). 
Oncogenic RNA-viruses differ in their action on the host cell 
from DNA-virus in that they can replicate without killing the cell. 
Moreover, they can achieve transformation and production of virus 
particles at the same time in one cell. In 1964 Temin proposed the 
hypothesis that RNA-virus produced a DNA-copy to secure these 
functions in the cell and in its progeny. In 1970 this theory was sub-
stantiated by the demonstration of the enzyme RNA-dependent 
14 
DNA-polymerase, within an RNA-virus (Temin and Mizutani 1970, 
Baltimore 1970). Since then this enzyme, now referred to as "reverse 
transcriptase" has been found in virtually all known oncogenic RNA-
viruses (Spiegelman e.a. 1970; Green e.a. 1970, Hatanaka e.a. 1970, 
Gallo 1972). The enzyme can induce the formation of a DNA-
sequence starting from a RNA-chain as template, the reverse of the 
once postulated "central dogma" of molecular biology. 
The detection of this reverse transcriptase in malignant tissue has 
even been interpreted in favour of the presence of oncogenic RNA-
virus, e.g. in milk obtained from patients with breast cancer (Schlom 
e.a. 1971). 
To explain tumour induction and virus release by radiation or 
chemical carcinogens, a pre-existing virus-DNA-segment in the 
genome of the cells has been suggested. Remarkably, this principle 
was first proposed for an RNA-virus. Bentvelzen (1968), working 
with mammary tumour virus, provided experimental evidence for the 
genetic transmission of a "provirus", which could instruct for virus-
RNA under certain conditions. He postulated that a DNA-sequence, 
complementary to the RNA of the free virus, was present in the 
genome of several mouse strains. In normal circumstances the tran-
scription of the provirus would be repressed in accordance with the 
Jacob and Monod model for bacteria. Radiation or chemical carcino-
gens (urethan) were postulated as derepressing the transcription of 
the DNA-copy and resulting in the production of virus-RNA and the 
transformation of the cell. 
This provirus concept has been supported by Weiss (1972) who 
was able to demonstrate the presence of a DNA-copy of an avian leu-
kosis virus (an RNA-virus) in the nuclear DNA of normal chicken 
cells by using the nucleic acid hybridization technique. A specific 
affinity between isolated viral RNA and chicken DNA suggested the 
presence of complementary structures in both nucleic acid chains. 
Huebner and Todaro (1969) extended this theory to a unifying 
concept of cancer, assuming that the cells of most if not all verte-
brate species have DNA-copies of C-type RNA virus in their genomes 
- "oncogenes" - which are vertically transmitted in a covert, 
"switched off' form. Physical or chemical inducers or senescence 
could "switch on" the oncogene and - depending on other factors -
this would result in any type of cancer. 
As a corollary of this hypothesis, in cancer cells the oncogene 
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should be activated and transcribed. If available techniques are suf-
ficiently sensitive, it might be anticipated that cytoplasmic RNA 
transcribed from these oncogenes could be demonstrated within 
malignant cells. Indeed, the nucleic acid hybridization technique was 
enabled Spiegelman and co-workers to provide evidence for the pre-
sence of RNA in human breast cancer cells which is complementary 
to the DNA copy obtained in vitro from a murine mammary tumour 
virus (Axel e.a. 1972). This complementary RNA was not found in 
non-malignant human breast tissue. Furthermore, there was no hy-
bridization with DNA copied from leukaemogenic virus. Remark-
ably, these results were obtained with mouse mammary tumour 
virus, as sufficient quantities of virus isolated from human milk were 
not available. These observations therefore suggest that human malig-
nancy might be expressed by the activity of genes which have much 
in common with those in the corresponding tumours in mice. Al-
though the RNA specific for murine mammary tumour also occurs as 
an infective virus particle, the conclusion that human cancer is virus-
mediated is not warranted, even if an identical RNA sequence would 
be demonstrated within the virus particles isolated from human milk. 
The data stress, however, the similarity of the genes which play a role 
in the malignant transformation in mice and man. 
Although virologists implicate physical and chemical agents in 
their theories on viral carcinogenesis it must be realized that many 
chemical compounds and radiation can in principle act by producing 
immunosuppression and thereby interfere with the removal of cells 
which are transformed by other means. In accordance with the sti-
mulation theory of cancer, regeneration in response to toxic or 
mechanical injury will also predispose to carcinogenesis. 
Finally, a difference in toxicity of carcinogenic agents for normal 
cells on the one hand and transformed cells on the other, could lead 
to selection of the latter and thus promote the development of 
cancer. 
H. Leukaemogenesis 
Leukaemias in general constitute diseases characterized by im-
moderate proliferation of haemopoietic cells which, just like other 
cancer cells, cross their natural barrier and infiltrate other organs and 
the blood. The fact that mature blood cells may already under nor-
mal circumstances pass into the blood stream does not preclude the 
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importance of cell-to-cell contact within the bone marrow and other 
haemopoietic organs, a factor which has only scarcely been explored. 
In acute leukaemias the normal diversity of cells in the bone mar-
row is replaced by a monotonous picture of blast cells. The predo-
minating cell type is called myeloblast or lymphoblast according to 
the degree of similarity which exists between the leukaemic cells and 
the normal precursors of myelopoiesis and lymphopoiesis, respective-
ly. 
The presence of a few granules in the cytoplasm of the blast cells 
and of transitional stages towards the promyelocyte among the blast 
cells are arguments for the diagnosis of myeloblastic leukaemia. The 
impression is gained of a maturation arrest at the myeloblast stage. In 
lymphoblastic leukaemia stages of maturation are less easily discern-
able. Here too, the morphological picture suggests a maturation de-
fect analogous to the myeloblastic leukaemia and probably compar-
able to the "de-differentiation" of solid tumours. 
Apart from morphological differences observed by light microsco-
py, there are, however, few criteria for the separation of these two 
kinds of acute blastic leukaemia. Careful electron microscopic studies 
by Bessis and Lajtha (1971) paradoxically revealed incipient myelo-
cyte granulation in blast cells of so-called lymphoblastic leukaemia! 
Only monoblastic leukaemia appeared to be characterized by a se-
parate type of blast cell. The more favourable results of chemothera-
py in acute lymphoblastic leukaemia as compared with those in mye-
loblastic leukaemia might be associated with the stage of maturation 
of the majority of the blast cells and probably also with the age dis-
tribution of the patients, the acute lymphoblastic leukaemia being 
the predominant type in children. At present, data on the kinetics of 
the different morphological types of acute leukaemia are insufficient 
to deal with them separately. 
With regard to the aetiology of human acute blastic leukaemia 
many causative agents have been incriminated, such as exposure to 
benzene, ionizing radiation, cytotoxic agents and other drugs capable 
of inducing bone marrow aplasia, and a virus. Only the aetiological 
role of relatively large doses of radiation can be regarded as proven, 
mainly by the association of leukaemia and therapeutic irradiation of 
the spine in ankylosing spondylitis, by the high incidence of leukae-
mia among radiologists and by the burst of leukaemia among the 
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survivors of the atomic bomb explosions in Hiroshima and Nagasaki 
(Hempelman 1960). However, lower doses do not seem to be harm-
less in this respect; low doses of radiation applied during diagnostic 
radiation of pregnant women raises the probability of leukaemia in 
their children by 40-50% (Stewart e.a. 1958, Ager e.a. 1965, 
McMahon 1962, Graham e. a. 1963, Gibson e. a. 1969). How radiation 
induces leukaemia is not yet clear but several possibilities have been 
considered: 
I) release or activation of a (pro)virus; 
2) immunosuppression, permitting the survival of transformed cells 
which would otherwise have been eliminated; 
3) regeneration, making the tissue more susceptible for neoplastic 
conversion; 
4) chromosomal injury. 
In mice the release of infective virus by radiation - even from 
low leukaemia strains- is well established (see Upton 1968). 
A recent investigation of the prevalence of leukaemia and 
lymphoma among the atomic bomb victims of Hiroshima and Naga-
saki suggested that leukaemia was associated with bone marrow 
hypoplasia, caused by relatively low radiation doses, whereas 
lymphomas were induced by higher doses which interfered with the 
immunological homoiostasis (Anderson e.a. 1972). 
Congenital human disorders, accompanied by chromosome de-
fects seem to predispose for the contraction of leukaemia (see 
Schroeder 1971 ). Whether the chromosome breaks are related to the 
action of a virus or to the activation of a provirus is still conjecturaL 
For benzene as a causative agent presumptive evidence also exists 
(Vigliani 1964). The reports of cases of blastic leukaemia after 
transient bone marrow aplasia should possibly be regarded in the 
light of the promoting effect of toxicity and regeneration or of other 
indirect factors involved in carcinogenesis. 
Despite intensive research direct proof of the viral aetiology of 
human leukaemia is still lacking. Yet, since the discovery by Epstein 
and Barr (1964) of a herpes virus in a cultured cell line of Burkitt 
lymphoma and of the serological evidence (Gunvim e.a. 1970, Zur 
Hausen e.a. 1970) for the causal relationship of this virus with both 
Burkitt lymphoma and infectious mononucleosis, (a "self-limiting 
leukaemia", Dameshek 1968), a widespread inclination to accept the 
viral aetiology of human leukaemia has been noted (Swaen 1969, 
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Dameshek 1969, Gunz 1970, Epstein 1971). 
The difficulties to prove this are manifold. In spite of many ex-
perimental attempts, the proof of the viral aetiology of murine leu-
kaemias had to wait half a century after the first successful cell-free 
transmission of avian leukosis by Ellerman and Bang in 1908 (re-
viewed by Tio 1927, Furth 1968, Gross 1970). 
The availability of inbred strains of mice with a genetically deter-
mined susceptibility has promoted the research considerably and 
especially so after the discovery by Gross (1951) that neonatal mice 
were more prone to develop leukaemia after inoculation of infectious 
material than were adult animals. 
The failure to detect infective particles in the past is all the more 
understandable now that it is known that a virus may disappear al-
most completely within the cell it has transformed into a tumour 
cell. 
Often the virus can be traced only by serological means, e.g. 
Shope's papilloma virus in the domestic rabbit, or by other indirect 
approaches. Some viruses are defective and need a helper virus 
(Huebner e.a. 1966) to rescue it from infected cells. If indeed a virus 
is produced from human leukaemic tissue (Dmochowski 1966, Priori 
e.a. 1971) the proof of the causal relationship can for obvious rea-
sons not be provided experimentally. Injection of human leukaemic 
tissue in primates has been consistently unsuccessful (Rauscher 
1968). Infection of human cells cultured in vitro seems to be the 
only promising substitution (Wright e.a. 1969, Todaro e.a. 1970). 
The EB-virus, which has been related to Burkitt's lymphoma and 
infectious mononucleosis, is a DNA-virus. In contradistinction, all 
known animal leukaemia viruses are of the RNA, C-type variety, and 
some investigators favour the idea that human leukaemia may be as-
sociated with C-type RNA viruses as well (Dmochowski 1970, 
Todaro e.a. 1970, Gross 1970, Gallo e.a. 1970). Indeed, C-type par-
ticles have been observed in human leukaemia (Braunsteiner 1960, 
Ames e.a. 1966, Dmochowski 1966, Dalton e.a. 1968). Perhaps the 
sucrose density sedimentation method as proposed by Todaro e.a. 
( 1970) will prove to be rewarding in this respect in the future. 
An exciting development in this field is the demonstration by 
Spiegelman and co-workers of RNA in human leukaemic cells which 
hybridizes with DNA copied from Rauscher leukaemia virus, but not 
with DNA-copies of unrelated viruses (Hehlman e.a. 1972). This 
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observation is analogous to that in human breast cancer, cited above. 
It might indicate that malignant haematopoietic cell proliferation 
both in the mouse and in man is accompanied - or even induced -
by the formation of a distinctive mRNA. This RNA can assume the 
shape of an infective virus particle, at least in the mouse. 
The epidemiological evidence produced so far for a virus in 
human leukaemia is scant (Fraumeni ! 969). However, the sporadic 
occurrence and the apparent noncontagious character are consistent 
with ordinary or even ubiquitous virus, rather than with a highly in-
fectious one (Fink 1968, McBeath e.a. 1968). It is questionable 
whether one distinct type of virus will be incriminated as the cau-
sative agent, or whether many types can produce the same disorder. 
The fortuitous success of Spiegelman c.s. who chose Rauscher leu-
kaemia virus for the detection of oncogene activity in human leukae-
mia cells seems to curtail the possibilities. 
The observations of Fialkow (1971) and Thomas e.a. (1972) of a 
donor-type blastic leukaemia in two irradiated patients who received 
their brother's bone marrow, has been adduced in favour of an exter-
nal agent, i.e. a virus, by the advocates of the virus theory. Believers 
in an immunological breakdown as a permissive factor in leukae-
mogenesis, on the other hand, prefer a different explanation (Fischer 
1971 ). Pertinent observations are awaited with interest. 
Stem cells in acute leukaemia 
The careful histological examination of haematopoietic organs at 
the turn of the century has focused attention on the origin of the 
various differentiated blood elements from a relatively small number 
of progenitor cells. A long debate has developed among pathologists 
and haematologists on the question whether all types of cells were 
derived during lifetime from one common ancestor or from two or 
more classes of precursor cells with a limited differentiating capacity 
(reviewed by Bloom !938). Only in recent years this problem seems 
to be settled in favour of the "unitarians", at least in the mouse 
(Becker e.a. 1963, Wu e.a. 1967, Fowler e.a. !967) and in the rat 
(Nowell e.a. 1970): and there are no reasons why one should expect 
a different situation in man. In this concept haematopoietic stem 
cells are regarded as undifferentiated cells which are capable of un-
limited self-replication and each of which has the potency to respond 
to an adequate stimulus to differentiate into any type of primitive 
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haematopoietic cell, ultimately providing a number of mature, spe-
cialized blood cells. The morphological identification proved to be 
difficult to establish because the concentration of these cells in the 
bone marrow is very low. The most likely candidate seemed to be a 
lymphocyte-like cell or "transitional lymphocyte" (Yoffey 1960, 
Cudkowicz e.a. 1964, Metcalf 1971 ), as was already postulated more 
than half a century ago (Dominici 1902, Maxim ow 1909, etc., see 
Bloom I.e.). Only recently, provocative evidence has been provided 
that the cell which fulfils the criteria for the pluripotent stem cell is 
distinct from the lymphocyte. This cell could be identified electron 
microscopically after its concentration in mouse bone marrow sus-
pensions either by freezing and thawing (Rubinstein and Trobaugh 
1970) or by gradient centrifugation (van Noord e.a. 1970, van 
Bekkum e. a. 1971 ). 
Despite the difficulties in recognizing the pluripotent stem cell in 
a population of haematopoietic cells from bone marrow or mouse 
spleen, a quantitative estimation of the stem cell content is possible. 
A practical technique has been provided by Till and McCulloch 
(1961) based on the potentiality of the pluripotent stem cell to grow 
out to visible colonies at the surface of the spleen of irradiated mice. 
During the last few years important steps to an in vitro method for 
the assay of stem cells have been taken by Pluznik and Sachs (1965) 
and by Bradley and Metcalf (I 966) and one is hopeful to achieve an 
in vitro system which is more or less equivalent to the classical spleen 
colony assay (Dicke 1970). The in vitro method has some obvious 
advantages over the in vivo techniques as regards the manipulation of 
all sorts of humoral stimulatory and inhibitory factors. The achieve-
ment of megakaryocyte differentiation in such colonies by the ad-
dition of thrombopoietin-rich plasma to the agar culture (Nakeff e.a. 
1970) is a striking example, and demonstrates at the same time the 
pluripotency of the colony forming cells. 
On the analogy of the pluripotent stem cell in the mouse and rat, 
the functioning of a similar stem cell in man has become the more 
likely. The clue to the existence of a pluripotent haemopoietic stem 
cell in human bone marrow comes principially from the circumstan-
tial evidence for the occurrence of an abnormal chromosome, the 
Philadelphia chromosome, both in myeloblasts and in erythroblasts 
as well as in megakaryocytes in chronic myeloid leukaemia (Whang 
e.a. 1963, Tough e.a. 1963). Likewise, indirect evidence has been 
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provided that the chromosomal aberrations sometimes encountered 
in acute myeloblastic leukaemia also occur in erythropoietic cells 
(Krogh Jensen 1967). In cases of acute myeloblastic leukaemia and 
in preleukaemic states the same abnormal karyograms have been 
found in bone marrow preparations and in cultures of peripheral 
blood, stimulated by phytohaemagglutinin. As lymphocyte meta-
phases are preferentially obtained with this latter method, this ob-
servation might indicate the existence of a common precursor to 
myelopoiesis and lymphocytopoiesis and even the involvement of 
this common stem cell in leukaemogenesis (Leeksma 1969). 
In recent years also for human material quantitative methods are 
available for the estimation of the stem cells in the bone marrow (see 
van Bekkum and Dicke 1972). However, it has not yet been proved 
that any of the currently used assay systems actually measures the 
pluripotent stem cell. 
Notwithstanding the excellent achievements of chemotherapy in 
the past decade, which has seen the increase of the remission rate of 
acute granulocyte leukaemia to more than 50% (Rosenthal e.a. 1972) 
and of childhood leukaemia to almost 100% (Hamilton Fairley 1971, 
Holland 1972), cure of leukaemia is seldom attained. The relapse rate 
regretfully remains high. According to Skipper ( 1968), virtually all 
leukaemic cells have to be eradicated to obtain a complete remission. 
However, may instances of unpredictably good response have been 
noted (Bernard 1965, Bierman 1967, Burchenal 1968). The factors 
which determine the response of a particular case of leukaemia to 
treatment are largely unknown. Even which cells are specifically 
attacked by the cytotoxic agents has not yet been satisfactorily re-
solved. It is generally assumed that rapidly dividing cells are selective-
ly affected, although this is difficult to reconcile with the observa-
tions that the greater part of the leukaemic blast cells are not pro-
liferating but inactive and out of the mitotic cycle (Killmann 1968c). 
If a complete remission is achieved promyelocytes and myelocytes 
appear after a phase of bone marrow aplasia and often norrnal hae-
matopoiesis is restored for a certain period of time. Regretfully, near-
ly always leukaemia recurs after a variable interval. Knowledge of the 
source of the normal bone marrow cells which repopulate the bone 
marrow in remission and of the leukaemic blast cells which reappear 
in relapse is scanty. Concerning this problem several hypotheses have 
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' Stem cells Differentiating and proliferating: 
' compartments ' 
:Mature blood cells 
Clonal theory of leukaemogenesis: leukaemic clone suppresses the progeny 
of normal stem cells 
II External influence theory: newly recruited cells from stem cell compartment 
are transformed to leukaemic cells 
Ill Leukaemia major - leukaemia minor theory of leukaemogenesis: all stem cells 
are leukaemic, but some of their progeny may appear norl'"flal 
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been brought forward of which the following three will be discussed 
(see schemata page 23). 
I. Killmann (1968b) has tried to elucidate both aspects of the 
problem by postulating a mutation of a pluripotential haemato-
poietic stem cell once in ontogeny or in adult life. Assuming that the 
original set of stem cells with which every individual is endowed 
from birth, gives off its members one by one, each being capable of 
populating the haematopoietic system for a limited period of time, 
the release of a leukaemic precursor depends on chance. When it is 
the tum of a leukaemic stem cell to feed the haematopoietic appara-
tus, a leukaemic progeny will appear and if the aberrant cells are 
viable and not eliminated by immunological or other mechanisms, 
leukaemia will ensue. After the induction of complete remission by 
chemotherapy the bone marrow is apparently repopulated by a 
surviving normal stem cell, the stem cells being less susceptible to 
agents whose efficacy depends on the mitotic activity of the target 
cells. However, as soon as the original leukaemic stem cell grows out 
to an appreciable number of cells, clinical leukaemia relapses. 
Chromosome analysis has provided evidence for the involvement 
of pluripotent stem cells in acute leukaemia. However, so far there 
are no strong arguments in favour of a constant influx of cells from 
this pluripotent stem cell pool into the population of leukaemic 
blasts. Attemps to demonstrate the alternative, i.e. the self mainte-
nance of the leukaemic blasts, have yielded contradictory results. 
The application of radioactive labeling techniques, especially the in-
corporation of tritium labeled thymidine (3HTdR) analysed by auto-
radiography, has revealed that in many tumours including leukae-
mias, the neoplasia consists of a small number of actively prolifera-
ting cells as against a majority of mitotically inactive, although im-
mature cells (Mendelsohn 1962, Gavosto e.a. 1964, Killman 1965, 
Baserga 1963, Mauer e.a. 1966, Frindel e.a. !968). The growth frac-
tion of leukaemic blasts at the time of diagnosis has been estimated 
to be in the order of 10-20% (Gavosto e.a. 1967, Mauer e.a. 1966, 
Killmann !968a) in contrast to an overall labeling index of about 
30% in normal granulopoiesis and a much higher growth fraction of 
normal myeloblasts. Consequently, the accretion of the cell mass in 
leukaemia must be due to the multiplication of a relatively small 
number of progenitor cells. The question whether these cells belong 
to the leukaemic blast cell population per se or to a separate 
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(pluripotent) compartment or both is one of the most intriguing. 
In studying the proliferating blast cells Gavosto e.a. ( 1967) found 
that more than 50% of these cells had decreased in size and remained 
small after the first devision i.e. between I 0 and 17 hours after pulse 
labeling (injection of 3HTdR in vivo) with the label being found in a 
non-proliferating pool on subsequent days. From this observation he 
concluded that the proliferating compartment was not self-main-
taining (Gavosto I.e.). However, the re-entry of the (small) non-
proliferating blast cells into the proliferative pool after therapeutic 
intervention or stimulation by U.V. light has been demonstrated by 
several investigators (Gabutti e.a. 1969, Saunders 1969, Chan e.a. 
1969, Clarkson e.a. 1970, Strijkmans e.a. 1970, Lampkin e.a. 1972), 
suggesting that the small secondarily labeled non-proliferating blast 
cells are not end cells but resting cells. It has not been decided 
whether the re-entry of temporarily non-proliferating blasts into the 
cycle can account for the maintainance of the proliferating cell pool 
in a steady state or whether an influx from an unrecognized stem cell 
compartment is necessary. 
According to the clonal theory there is a normal stem cell pool 
besides the supposedly leukaemic cells. When all less primitive cells 
are destroyed by chemotherapy, the difference in proliferative speed 
will favour the return of normal haematopoiesis. In fact, contrary to 
the former belief that neoplastic cells devide faster than normal cells, 
recent research has shown that in many tumours and in most cases of 
blastic leukaemia the malignant cells divide slower than normal cells 
(Baserga 1965, Killmann 1965). The average generation time, i.e. the 
interval of time between successive mitoses, is longer than normal in 
leukaemia (Killmann 1963, Saunders e.a. 1967) and the blast cell 
production rate, which has been calculated by Killman (1968c) from 
available data, is less than the production rate of normal multiplica-
ting granulocytic cells. 
Thus it is conceivable that after chemotherapy the normal stem 
cells repopulate the bone marrow and release normally functioning 
blood cells before the leukaemic cells return in detectable numbers. 
The results of the in vitro colony growth technique applied to 
human leukaemic bone marrow revealed the paucity of colony 
forming cells in relapse (Senn e.a. 1967, Harris and Freiriech 1970) 
and an almost normal number in remission (Greenberg e.a. 1971) of 
blastic leukaemia. Concomitantly, the colony stimulating activity 
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emanating from normal granulocytes was lacking in relapse of blastic 
leukaemia and returned in remission (Robinson e.a. 1970, Greenberg 
e.a. 1971 ). The latter author regarded these findings in favour of the 
clonal origin of leukaemic blast cells. 
II. An alternative hypothesis is that in leukaemia the stern cells 
remain normal, the leukaemic transformation occurring only on their 
way to differentiation into committed haernatopoietic precursor 
cells. This hypothesis assumes the presence of a transforming agent 
throughout the lPukaernic disease, possibly a virus. An argument for 
an external factor in man has recently been provided by the observa-
tion of Fialkow e.a. (1971) and Thomas e.a. (1972): in their patients 
acute leukaemia relapsed after total body irradiation and bone marrow 
transplantation; the leukaemic blasts in relapse proved to be of donor 
origin, suggesting, the presence of a transforming agent in the host. 
This external influence theory seems difficult to reconcile with 
the conception of an unicellular origin of the leukaemic tissue as is 
held in the sleeper-to-feeder stern cell hypothesis of Killrnann 
(1968b) ~ in which the functional state of a stern cell depends on 
the distance from the fertilized ovum ~ unless one supposes that the 
transformation occurs after the sleeper or even after the feeder stage. 
This latter idea is supported by chromosome studies in human leu-
kaemia. In many cases of blastic leukaemia chromosomal abnormali-
ties are found. However, the same chromosomal changes are never 
seen in all rnetaphases and if one admits that all cells with a particu-
lar chromosome pattern belong to one clone, different clones can be 
found in the leukaemic population of blood or bone marrow of the 
same patient. The observation of Leeksrna e.a. ( 1970) of chromoso-
mal aberrations emerging and disappearing during a preleukaernic 
state without altering the clinical course also substantiates the view 
that the leukaemic cell mass as a whole might consist of multiple and 
succeeding clones which are not necessarily derived from one leukae-
mic stern cell. 
The increase in the incidence of new karyotypes with increasing 
survival in chronic myeloid leukaemia (Whang-Peng, see Gallo 1972) 
also argues for this conception. 
III. The third hypothesis which tries to explain the occurrence of 
mature cells in complete remission is the "leukaemia minor" -theory 
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of Killman ( 1968b ). Leukaemic transformation need not be an all or 
non phenomenon. If conditions are favourable transformed precursor 
cells might differentiate into mature, morphologically slightly abnor-
mal end cells, so-called "leukaemia minor" cells, in contrast to leu-
kaemia major cells. Indeed, in acute leukaemia abnormalities in 
mature granulocytes are often seen, e.g. poor granularity, Dohle 
bodies, pseudo-Pelger-cells, etc., the origin of which is poorly under-
stood. Even if morphologically indistinguishable from normal the 
function of neutrophils in leukaemic patients can be substantially im-
paired (Holland e.a. 1971 ). 
According to Killmann's hypothesis, haematopoiesis in remission 
could temporarily be run by leukaemic precursor cells. One of the 
sources of "leukaemia minor" cells could be the leukaemic blasts. In-
deed, leukaemic myeloblasts not only can resume DNA-synthesis as 
discussed before, but also evidence has been provided that they can 
give rise to mature granulocytes in vitro (Robinson e.a. 1970). This 
hypothesis raises the rather pessimistic conception that all efforts to 
eradicate the leukaemic cell population are in vain, because remission 
depends on the progeny of leukaemic cells! However, virologists 
have propagated the consoling knowledge that oncogenic factors may 
be stowed away in the genome of a cell without causing transforma-
tion. In the future, the repression of the oncogene might become the 
prime goal for the maintenance therapy of complete remission of 
acute leukaemia. 
Purpose and design of the present study 
At present more arguments are needed to prove the validity of 
any of the hypotheses on leukaemogenesis. The main object of this 
study was to investigate the role of the pluripotent stem cell in leu-
kaemia. For this purpose an experimental model was chosen, namely 
Rauscher Murine Leukaemia. The arguments for this choice are dis-
cussed in Chapter II. In the same chapter a survey of the litterature is 
given on Rauscher leukaemia, especially regarding the neoplastic 
nature of the disease and concerning the target of the virus. 
Since this disease displayed a different course when it was in-
duced by different experimenters, as discussed in Chapter II, the first 
aim of this study was to check the natural history of Rauscher Leu-
kaemia in mice, under the circumstances prevailing in our laboratory 
and induced by the virus preparation available (Chapter IV). 
27 
To characterize the disease further and to examine the autono-
mous growth potential of the leukaemic cells, these experiments 
were extended with studies on the transplantability of the leukaemic 
cells (Chapter IV). 
Taking advantage of the availability of a stem cell assay in mice, 
the presence of stem cells in the enlarged leukaemic spleens of the 
infected mice was assessed quantitatively by the spleen colony assay 
(Chapter V). 
Evidence was sought for the differentiative capacity of the stem 
cells of the leukaemic spleens by the analysis of the types of cells 
constituting the colonies which emerge from the leukaemic stem cells 
when they are injected in lethally irradiated recipients, and by the 
attempt to prolong the survival of the lethally irradiated mice by the 
injection of leukaemic spleen cells (Chapter V). 
The question whether the stem cells are involved in this murine 
leukaemia was approached by the search for viral antigens upon the 
cell membrane of the colony forming stem cells (Chapter V). 
Leukaemia developed in mice restored with leukaemic spleen cells 
after lethal irradiation. Nevertheless, these animals survived longer 
than unirradiated mice, infected with the virus. Some characteristics 
of these restored mice are recorded in Chapter VI. 
The results of the experiments are discussed in general and a 
hypothesis on leukaemogenesis is proposed (Chapter VII). 
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CHAPTER II 
RAUSCHER MURINE LEUKAEMIA 
A major obstacle in the understanding of the mechanism of leu-
kaemogenesis is the ignorance of the level at which the presumptive 
leukaemogenic agent has its impact upon the haematopoietic system. 
This gap in our knowledge should be closed, not only to arrive at a 
more rational chemotherapy, but also to allow the development of 
other therapeutic approaches, e.g. immunotherapy. Should the the-
rapy be aimed at the pluripotent stem cell, either by selection of the 
therapeutic agent or by manipulation of the stem cell into a sus-
ceptible state? Or should the pluripotential stem cell be spared? 
Especially when efforts are undertaken to treat leukaemia by the cor-
rection of the deranged differentiation, knowledge of the involve-
ment of the various stages of differentiation in haematopoiesis is es-
sential. 
Choice of the experimental model 
For the study of the role of the stem cell in leukaemogenesis an 
animal model was selected. A murine leukaemia appeared to be the 
most convenient because of the ready availability of the test animal 
and the ease with which leukaemias can be induced in mice. Further-
more, in the mouse the stem cell population can be estimated quan-
titatively by the spleen colony assay, as indicated before. Until equi-
valent techniques for the essay of the pluripotent stem cell are 
feasable in other animal species and man, the mouse has a great ad-
vantage for the study of haematopoietic cell differentiation. 
Several types of spontaneous leukaemia have been encountered in 
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mice and various types can be induced, either by radiation or by che-
mical carcinogens, by virus infection or by transplantation of leukae-
mic cells. Most leukaemias in the mouse, among them spontaneously 
occurring leukaemias as well as induced ones, are of thymic origin 
and can be compared with lymphatic leukaemias in other animals 
and man. Since differentiation of lymphocytes is difficult to re-
cognize morphologically, these leukaemias were considered not to be 
suitable for the proposed study. Myelogenous leukaemias have the 
disadvantage to occur only rarely even if specifically induced; more-
over the incubation period is generally long (Siegler and Rich 1967). 
At the time this study was started a myelogenous leukaemia was not 
available. 
Transplantable leukaemias are mostly caused by the proliferation 
of a single or few cells which grow exponentially after transfer to a 
new recipient without a normal differentiation pattern. The kinetics 
of the proliferation of transplanted leukaemia cells differ strongly 
from those of spontaneous Jeukaemias, especially with respect to the 
growth fraction, - which is almost I in the L 121 0 leukaemia, - the 
absence of cells in G0 and the time parameters of the cell cycle (Gavosto 1970). Furthermore, a pluripotent precursor of the trans-
plantable neoplastic cells cannot be detected. Spleen colonies can be 
obtained by injecting leukaemic cells in irradiated and often even in 
non-irradiated recipients (Bruce e.a. 1963, Tanaka and Lajtha 1969), 
but there is no evidence yet that the tumour-colony forming cells are 
pluripotent stem cells. In the transplantable leukaemias the spleen 
colony formation only permits the estimation of the fraction of 
"stem cells" in the leukaemic population, in the sense of those cells 
which are endowed with the ability of self replication and are 
responsible for the proliferation of the leukaemic population. ln the 
most widely used type of transplantable leukaemia. L 1210, this frac-
tion is ± I 00%. In some transplantable myeloid leukaemias, e.g. that 
studied by Tanaka e.a. ( 1970), an indication can be obtained that 
some colonies might have arisen from multipotential precursors. 
Metcalf e.a. ( 1969, 1970) observed colony formation in vitro by cells 
from a myelomonocytic leukaemia, originally transplantated in mice 
by Warner e.a. (1969). They observed various cells of the myeloid 
series as well as "macrophages" in these colonies. However, until the 
culture systems are further improved so as to permit induction of 
any direction of differentiation, no conclusions can be attained 
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about the pluripotency of the cells forming the colonies in vitro. In 
conclusion, transplantable leukaemias are not suitable as models for 
human leukaemias when the study of differentiation is the goal. 
The advantages of a virus-induced leukaemia as an experimental 
model as compared with chemically and radiation-induced leukae-
mias are among others the high rate of response of the appropriate 
host to virus infection and - at least with some viruses - a short 
incubation period. As available models for lymphatic leukaemias 
were considered unsuitable for reasons mentioned before, an erythro-
blastic leukaemia was chosen, namely that induced by Rauscher Leu-
kaemia virus (RL V). This disease is very similar to Friend disease 
(Dmochowski e.a. 1966, Siegler and Rich 1967), which was dis-
covered earlier (Friend 1957) and was regarded by others (Metcalf 
e.a. 1959) "an excellent object for the study of tumour-virus rela-
tionships". 
Rauscher Murine Leukaemia 
In 1962 Rauscher described a hitherto unknown murine leukae-
mia in BALB/c mice. This leukaemia was fortuitously elicited by the 
inoculation of a filtered extract of a serially transplanted intraperito-
neally growing lymphoblastoma, obtained in an attempt to isolate an 
oncogenic virus from the Schoolman-Schwartz lymphoblastoma. The 
filterable leukaemogenic agent which could not be reisolated from 
the original tumour, proved to be a C-type virus, present in large 
amounts in plasma pellets and within the megakaryocytes of leukae-
mic animals. 
Serial passage of virus recovered from the spleens of these mice 
resulted in increased potency which was manifested by a higher in-
cidence of leukaemia (95-100%) and by a decrease in the interval of 
time between inoculation and splenomegaly or death (Rauscher 
1962). 
If a large dose of virus was injected in young BALB/ c mice, the 
spleens became palpable within 10-15 days and most animals died be-
tween 28 and 35 days after inoculation. The spleens of these mice 
eventually became grossly enlarged and reached weights of 3-6 gr. 
The texture of the spleens was spongy due to the presence of mul-
tiple haemorrhages. Usually, hepatomegaly was also observed. 
Lymph nodes and thymus were normal or only moderately enlarged. 
Microscopic examination revealed a crowding of nucleated red cells 
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and erythroblasts in the red pulp of the spleen and in the liver 
sinusoids. In some lymph nodes an accumulation of granulocytes was 
found. The thymus appeared to be atrophic. Peripheral blood smears 
showed a large number of nucleated red cells. 
In mice which survived the early splenomegaly a lymphocytic leu-
kaemia was noted, beginning 30-45 days after inoculation of the 
virus. Thymus, lymph nodes and spleen in these animals were infil-
trated by large mononuclear basophilic cells. In the liver these cells 
accumulated in the portal triads. Many lymphocytic cells appeared in 
the peripheral blood. 
To explain the dual character of the disease the possibility of the 
presence of two viruses in the same preparation was considered. 
However, no evidence for this was found at that time, neither by 
electron microscopy of the tissues of the erythroblastic and lympho-
cytic disease, nor by serial passage or dilution of the preparations. 
Rats or newborn c57BL mice inoculated with large doses of 
virus, developed lymphocytic leukaemia without preceding erythro-
blastosis (Rauscher 1962). 
Since the original description of this new murine leukaemia the 
disease has been studied in many laboratories. Regarding the initial 
splenomegaly and erythroblastic proliferation, these observations 
have been widely confirmed. This aspect of the disease appeared to 
be indistinguishable from the erythroblastic disease induced by the 
Friend virus (Siegler and Rich, 1964) and from the murine erythro-
blastosis in C3HF /G3 mice described by Kirsten e.a. (1967). A simi-
lar disease has been induced in BALB/c mice by the combination of 
antilymphocyte serum and Moloney leukaemia virus (Varet e.a., 
1971 ), which is presumably contaminated by erythroblastosis-
inducing viruses. 
In BALB/c mice infected with a high dose of Rauscher virus a 
severe anaemia was found (Boiron e.a. 1965, Brodsky e.a. 1969, 
Seidel 1972, Ebert e.a. 1972). The decrease of the haematocrit 
was accompanied by a considerable reticulocytosis which correlated 
with the dose of virus (Brodsky e.a. 1969), but, obviously, failed to 
compensate for the lack of erythrocytes. The anaemia has been 
ascribed to a combination of haemolysis and bone marrow failure 
and was potentiated by splenectomy (Brodsky I.e.), which suggests 
that splenic erythroblasts contribute some mature cells to the peri-
pheral blood. However, Seidel (1972) observed a rise of the reticulo-
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cyte count of only twice normal despite a decrease of the haemato-
crit to less than half its normal value, indicating an insufficient 
erythrocyte production in response to the severe anaemia. As the 
spleen is crowded with erythroblasts, this suggests that the splenic 
erythropoiesis in Rauscher leukaemia is mainly ineffective. 
Although in all laboratories experimenting with this murine leu-
kaemia the virus stems from the original one isolated by Rauscher, 
the observations with respect to the late phase of the disease differ 
considerably. 
Boiron e.a. (1965) made a systematic histological and cytological 
study of Rauscher disease in BALB/c mice, C57BL mice and in 
Wistar rats. In BALB/c mice they found an initial erythroblastic 
proliferation. A second phase of generalized myeloblastic leukaemia 
was seen in most animals who received such a low dose of virus that 
they survived the first phase. This myeloblastic leukaemia originated 
in the bone marrow and seemed to proceed from immature granulo-
cytic cells discernable already in earlier stages by careful histological 
and cytological examination. In the opinion of these investigators 
Rauscher disease in BALB/ c mice is a true erythroleukaemia. 
The neonatally infected c57BL mice reacted with a myelocytic 
leukaemia, sometimes presenting itself as a chloroleukaemia. A 
lymphatic leukaemia was never observed in mice inoculated with 
Rauscher virus. In the infected rats, however, lymphatic leukaemia 
was found exclusively. Others observed also in the second stage of 
Rauscher disease in mice only lymphatic leukaemias (Siegler and 
Rich 1964, Dunn and Green 1966, Brodsky e.a. 1967, 1968). 
Fieldsteel e.a. (1969a) reevaluated the reported dual ability of 
Rauscher's original first passage isolate. Both splenic disease and 
lymphatic leukaemia were observed but not in the same animal. With 
later passages of the virus the lymphatic disease could not be induced 
in mouse strains which were susceptible to the erythroblastosis. 
These authors concluded that the Rauscher virus preparations prob-
ably contained a mixture of at least two viruses, one of which in-
duced the early splenic response and the other a lymphatic leukaemia 
after a long incubation period. To explain the failure of later passages 
of the virus to induce lymphatic leukaemia in BALB/ c mice they ad-
vanced the idea of a preponderance of the erythroblastosis-inducing 
agent, which kills most animals long before the incubation period of 
the lymphatic leukaemia is expired, as already suggested by Dunn 
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and Green (1966). 
There is evidence that the dual character of Friend disease, an 
early erythroblastic response and late lymphatic leukaemia, is due to 
the presence of at least two viruses in the preparations. Dawson e.a. 
( 1966) showed that continued passage of Friend virus in rats yielded 
a virus which had permanently lost the capacity to induce the 
erythroblastic phase, but retained the capacity to induce lymphatic 
leukaemia. Steeves e.a. (1970, 1971) demonstrated the defectiveness 
of the erythroblastosis-inducing virus and showed that it needs a 
helper virus to display its pathogenicity. This helper function was 
exerted by the lymphatic leukaemia virus, present in a much higher 
concentration than the erythroblastosis virus. 
By similar approaches evidence has been provided for the pre-
sence of a dual population of viruses in Rauscher virus preparations. 
Swaen (1966) found that the virus produced a thymic lymphoma in 
rats. The virus recovered from these rats produced only lymphatic 
leukaemia in BALB/c mice, suggesting that one component out of a 
mixture of viruses has been separated in this biological system. In a 
similar experiment Gross (1966) found that antiserum against Gross 
virus inhibited the induction of lymphomas by the rat-adapted 
Rauscher virus. He concluded that the Rauscher virus consisted of a 
mixture of Friend and Gross virus. 
lshimoto and Maeda (1970) have carried out serial transplanta-
tions of lymphomas originally induced by Rauscher virus in C57BL/6 
mice. The initial virus preparations and the cell free extracts of the 
first passages rapidly induced hepatosplenomegaly with erythroblas-
tosis in susceptible mouse strains (SMA and BALB/c) as well as 
lymphomas in c57BL/6 mice. Extracts of long-transplanted lympho-
mas did not initiate early erythroblastosis. However, the ability to 
induce lymphomas in c57BL/6 mice did not disappear. This diver-
gence of the activities of the virus to induce either erythroblastosis or 
lymphoma with successive transplant passages might also be inter-
preted as evidence for the presence of two different viruses in the 
original preparation. 
Further evidence for a complex of viruses in the Rauscher virus 
preparations has been obtained by titration studies, using the spleen 
focus formation as a measure for the response to the virus: after in-
oculation of a low dose of virus into susceptible mice clusters of cells 
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appear at the surface of the spleens; these clusters are composed of 
primitive erythroid cells which are thought to originate from one 
transformed cell in each cluster. These clusters or foci can be 
counted with the naked eye. Whereas Pluznik e.a. (1964) observed a 
linear relationship between the dose of virus and the number of foci, 
Bentvelzen (1972) found an exponential rise of the number of foci 
with increasing dose of virus, indicating a multiple hit event. This not 
only suggests that there is a mixture of viruses in the injected pre-
parations, but also that at least two viruses help each other in pro-
ducing the effect (Brommer e.a. 1971 ). 
Probably the many passages of the virus in the various laborato-
ries have modified the composition of the different virus prepara-
tions used. For example, one of the recognized contaminants in some 
laboratories (Hanna e.a., 1970, Bennet e.a., 1970) but absent in 
others (Bentvelzen 1971) is the lactic dehydrogenase-elevating virus. 
It is conceivable that various amounts of this or other viruses might 
play a role as helper virus or even as primary infectants and define 
the outcome of the disease. 
In conclusion, the erythroblastosis is characteristic for the murine 
disease induced by Rauscher virus; the experience of the students of 
Rauscher leukaemia differs with respect to the second phase, some 
describing a lymphoma or lymphatic leukaemia, others a myelocytic 
leukaemia. 
From the quoted literature it seems likely that the virus prepara-
tions contain a mixture of virus. The erythroblastosis virus probably 
is only pathogenic if promoted by a helper virus, be it a lymphatic 
leukaemia virus or a virus, inducing myelocytic leukaemia. 
The neoplastic nature of Rauscher.erythroblastosis 
About the leukaemic nature of the second phase of Rauscher's 
disease there seems to be no doubt in the literature. The similarities 
to other leukaemias obviously are great enough to warrant the 
epithet malignant for this disease. However, with respect to the first 
phase of this disease, opinions about the nature of the erythroblastic 
proliferation diverge. 
The arguments in favour of a malignant process include the uni-
form proliferation of largely undifferentiated elements and the in-
vasion of these cells into the spleen and the liver, resulting in the 
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destruction of the architecture of these organs (Boiron e.a. 1965). 
The neoplastic character of the erythroblastosis is pleaded also by 
Siegler ( 1968) who prefers to can it a leukaemia by virtue of the dis-
semination of the cells to the periferal blood and its fatality for the 
host. In his opinion, the lack of autonomy of the erythroblastic cens 
does not contradict the neoplastic nature of the disease. In connec-
tion with this he refers to other malignant tumours which do not 
form metastases and are not readily transplantable. The same argu-
mentation has been applied to Friend disease (Metcalf e.a., 1959). 
On the other hand Dunn and Green (1966) argue for the non-
neoplastic nature of Rauscher's disease. Their arguments include the 
rapidity of induction, which would be unusual for animal Jeukae-
mias, and the presence of cens in various stages in differentiation in 
the enlarged organs, instead of a uniform cen population. However, a 
certain amount of criticism can be raised against the latter point. In 
many human tumours, e.g. in wen differentiated squamous cen carci-
noma, a considerable fraction of cens is more or less differentiated 
without giving doubt as to their neoplastic nature. The arguments 
that the disease is confined to the haematopoietic organs and that 
subcutaneous transfer to other mice does not result in local growth, 
is not valid because this depends on the Jack of autonomy of the 
erythroid cens, which is not a conditio sine qua non for malignancy. 
The accumulation of proliferating erythroblasts in liver and spleen 
and the failure of these cells to mature at a normal rate was not re-
garded sufficient for defining it as neoplastic. It can, however, be 
argued that these aberrations are in fact characteristic features of 
malignancy, discriminating it from simple hyperplasia and from 
aspecific reactions upon stimuli and infective agents. 
Other advocates for the non-neoplastic nature of the altered 
erythropoiesis in the initial phase of Rauscher Leukaemia are 
Brodsky e.a. ( 1967). They derive their arguments from the reversion 
of some erythropoietic parameters in the third week after infection. 
It seems questionable, however, whether the ferrokinetics they 
studied, reflect the proliferation of the immature cen mass in spleen · 
and liver. 
Spontaneous regression of erythroblastosis induced by Friend or 
Rauscher virus has been described either in a particular strain of mice 
(Dawson & Fieldsteel 1969, 1971) or after X-irradiation (Gallien-
Lartigue e.a. 1969). In both cases a correlation with diminishing virus 
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titers has been found. These observations cannot be adduced in 
favour of the non-neoplastic nature of Friend and Rauscher disease 
in BALB/ c mice because the susceptibility of the host to the virus 
resp. the X-ray treatment plays a major role. Moreover, spontaneous 
regression has also been observed in human leukaemia (see Dameshek 
and Gunz 1958). 
In conclusion, the workers in this field disagree in their opinion 
about the question whether the erythroblastosis induced by Friend 
or Rauscher virus be neoplastic or otherwise. On the one hand, this 
phase of the disease might be classified as malignant by its clinical 
behaviour, but other arguments for the neoplastic nature are difficult 
to obtain. The common criteria of malignancy, among which auto-
nomy and infiltrative growth, are hardly to prove in leukaemia. On 
the other hand, it is difficult to maintain the compensatory character 
of the splenomegaly in erythroblastosis if the spleen weight surpasses 
2 grams! Admittedly, the anaemia may in part be due to haemolysis 
and compensatory mechanisms may contribute to the erythroblastic 
proliferation, but this does not refute the neoplastic nature of the 
underlying disease. Likewise, in the Di Guglielmo syndrome in man 
the erythroblastic proliferation can partially be regarded as an at-
tempt to compensate for the low erythrocyte count which results 
from a myeloproliferative disorder (Adamson and Finch 1970). 
Thus, even if the erythroblastosis of Rauscher disease were mainly a 
temporary phenomenon of an irrefutably malignant leukaemia, as 
most authors agree, the study of the stem cell in this phase of 
Rauscher disease might be relevant to leukaemogenesis in general. 
The target of Rauscher Leukaemia Virus 
The erythroblastic proliferation dominates the morphological pic-
ture of Rauscher disease from the very beginning of the pathological 
changes. A few days after injection of the virus, groups of young cells 
can be found in the spleen, often designated reticulum cells, 
which soon differentiate to erythroid cells, coalesce to large areas 
and bring about the enormous splenic enlargement. In the sinusoids of 
the liver these cells appear shomewhat later than in the spleen. Their 
number gradually increases until the liver parenchyma is largely re-
placed by the immature erythroblasts. Eventually erythroblasts also 
crowd the bone marrow (Rauscher 1962, Dunn and Green 1966, 
Siegler 1968, Seidel 1979). In the terminal stages normoblasts enter 
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the blood stream where they may constitute 30-60% of the nucleated 
cells (Hopkins e.a. 1965, Seidel 1969) or more (Boiron e.a. 1965). 
Understandably, this disease has been regarded as a disorder of 
the red cell system. This view was substantiated by the elegant ex-
periments of Pluznik e.a. (1966) which permitted to define a target 
for the virus. These experiments were based upon the spleen focus 
forming ability of Rauscher virus. If injected into intact susceptible 
mice in relatively low doses the virus induces macroscopically visible 
clusters of cells upon the surface of the spleen which can be shown 
to consist of erythroid precursor cells. Short-term exposure of the 
recipient animals to hypoxia in order to stimulate erythropoiesis be-
fore the injection of the virus, resulted in an increase of the number 
of spleen foci. Suppression of erythropoiesis by polycythaemia 
caused a decrease of the number of foci. Concominantly the titer of 
virus in the blood rose or fell. The authors concluded that cells in an 
early stage of erythroid differentiation are the target of RLV. When 
they presented these data at the Conference on Murine Leukaemia in 
Philadelphia in 1965 the view of the authors was supported by 
Axelrad who had performed analogous experiments with Friend leu-
kaemia. 
The experiments performed by Tambourin e.a. ( 1969) with 
Friend leukaemia to define the target cells for this virus provided 
similar data. These investigators measured the rate of increase of the 
spleen weight after virus injection as a parameter for the response to 
the virus. They observed an acceleration of the course of Friend 
disease whenever the erythropoiesis was stimulated, and a slowing 
down of the process when the erythropoiesis was inhibited either by 
polycythaemia or by actinomycin D (Tambourin e.a. 1971 ). They 
concluded that the infected cells were probably identical to the ery-
thropoietin responsive cell (ERC), defined by Gurney e.a. (1962). 
The question whether the affected cell be uni- or multi potential was 
left open. 
The observations by Pluznik e.a. imply that the course of the 
disease is determined by the number of differentiated erythroid cells, 
present at the moment of infection, whereas the French authors 
assume that it depends on the number of undifferentiated cells. This 
incongruity is further stressed by the observation of the French 
group that virus-infected polycythaemic mice responded to i.p. in-
jections of erythropoietin with an accelerated spleen growth. This 
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signifies in the first place that the virus itself exerts no erythro-
poietin-like effect and in the second place that erythropoietin is 
needed for the full effect of the virus on erythropoiesis, not only in 
the initial phase, but also for the maintenance of the proliferation. 
Indeed, Dunn e.a. ( 1966) could prolong the survival of mice infected 
with Rauscher virus by suppressing erythropoietin production by 
repeated blood transfusion. 
The discrepancy between the different observations could be ex-
plained by postulating that the virus attacks at a still more primitive 
level of haematopoiesis and that the ensuing proliferation of haema-
topoietic cells remains dependent on regulatory mechanisms. Ery-
thropoietin-induced differentiation into the erythroid direction 
would "trigger" the unrestrained proliferation underlying the ery-
throblastosis. 
A distinct strain of virus, isolated from the Friend virus complex 
by Mirand (1967) does display an erythropoietin-like effect, as has 
been demonstrated in hypertransfused polycythaemic mice (Mirand 
1968). The virus itself produces polycythaemia in susceptible mice in 
conjunction with the erythroblastosis and splenomegaly, inherent to 
the Friend virus complex. The effects of this Mirand-strain of virus 
cannot be compared to Rauscher's disease without further comment. 
From several data reported in the literature it can be deduced 
that a more primitive cell than a proerythroblast or an erythro-
poietin-responsive cell is involved in leukaemogenesis upon Friend 
virus injection. 
In spite of the predilection of the spleen for the proliferation of 
leukaemic cells in this disease (Metcalf 1959) the bone marrow ap-
pears to contain as many or even more target cells for virus replica-
tion and transformation on a per cell basis than the spleen, as shown 
by Thomson (1969). Since the bone marrow contains more colony 
forming cells than the spleen she suggested that these are the target 
cells for the virus. 
A more direct approach to the question which cell type har-
boured the virus has been performed by providing evidence for the 
presence of viral antigen in the colony forming cells both of the 
spleen (Steeves 1968, Thomson and Axelrad 1968) and of the bone 
marrow (Thomson !969). The technique employed was a modifica-
tion of the spleen colony assay: the spleen or bone marrow cells to 
be injected were incubated with mouse- anti-Friend virus antiserum 
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and Guinea pig complement. As compared to the control suspension 
incubated with Guinea pig serum only, a great reduction of the num-
ber of colony forming units was noted, amounting to 95% (Steeves 
I.e.) or even more (Thomson I.e.). In their original articles the 
authors conclude that spleen and bone marrow of the infected mice 
contained a mixture of normal colony forming units and "tumour-
colony forming units". However, the few cells escaping the cytotoxic 
action of the antiserum are not necessarily different from the sen-
sitive cells. On the other hand, the designation "tumour-colony 
forming unit" seems to be premature. Although the spleen colonies 
produced by the injection of cells from Friend virus-infected spleens 
resemble the foci provoked by the injection of the virus in suscepti-
ble mice (Thomson and Axelrad 1968), there are to our knowledge 
no reports in the literature which state the incapability of the virus 
bearing colony forming cells to differentiate to normal end cells and 
to repopulate the damaged haematopoietic organs of irradiated reci-
pients and prolong their survival. In Rauscher disease (Brommer and 
Bentvelzen 1970) the colony forming cells derived from the infected 
spleens proved to be capable to restore the haematopoietic system of 
supralethally irradiated mice. The number of cells required for 50% 
survival after at least 30 days was not significantly different from 
that of normal spleen cells. There was no indication of a minor popu-
lation of normal colony forming cells together with a majority of 
"tumour-colony" forming cells. The failure to prolong survival of 
lethally irradiated mice by the injection of Friend virus-induced leu-
kaemic cells, harvested from an established tissue culture line (Rossi 
and Friend 1967), permits no conclusions about the repopulating 
ability of spleen cells from virus-infected animals. 
For the electron microscopic localization of the virus the spleen 
colony technique has been employed by Rossi e.a. (1971). For its 
replication Friend virus requires living haematopoietic cells. The in-
ability of the virus to replicate and to produce viraemia in lethally 
irradiated mice could be prevented by the injection of bone marrow 
or spleen cells prior to the injection of the virus as was demonstrated 
previously (Axelrad and Thomson, 1969). The virus will lodge and 
multiply in the spleen colonies. Electron microscopic examination of 
II days old colonies in restored and virus-infected mice revealed 
virus particles, budding from the surface of primitive haematopoietic 
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cells, but not of the recognizable erythroid cells. 
Of course, the presence of virus within a cell and even the replica-
tion of virus mediated by the genome of the host cell, is not equi-
valent to the transformation of this cells. Only if other changes are 
noted concomitantly, for example behavioral alterations, transforma-
tion can be assumed to have occured. The autonomous growth 
potential displayed by haematopoietic cells one day after Friend 
virus infection - as manifested by the capacity to proliferate in un-
irradiated hybrids - has been regarded as the earliest sign of Friend 
virus-induced transformation (Rossi e.a. 1970). Possibly this reflects 
such a behavioral change of the colony forming cell. 
The idea that Rauscher virus attacks the stem cell was already 
launched by Siegel and Morton in 1966b. They observed depressed 
antibody formation in mice infected with Rauscher virus and sup-
posed "a competition between virus and antigen for a stem cell that 
has immunoproliferative potentials as well as being subject to neo-
plastic direction by the virus, these two courses of development 
being mutually exclusive". The administration of Freund adjuvant 
prior to the virus inoculation appeared to render the mice more sus-
ceptible to the virus. Supposing that Freund adjuvant caused an in-
crease in the number of stem cells, this observation would support 
the hypothesis of the competitive interference at the stem cell level. 
Indeed Boggs e.a. (1967) and McNeill ( 1970) showed that Freund 
adjuvant produced an increase in the number of colony forming units 
in the bone marrow and the spleen of mice. However, the competi-
tion of these two systems at the level of the stem cell is independent 
of the site of impact of the respective stimuli. In the same experi-
mental system Siegel and Morton tried to retard the leukaemic re-
sponse to Rauscher virus by extensive antigenic stimulation of the 
mice before virus inoculation. The antigen stimulated animals 
showed an increased survival as compared to the unstimulated con-
trol animals. This effect appeared not to be due to the production of 
a virus neutralizing antibody but instead was attributed by the 
authors to a decrease in the number of target cells available to the 
virus as a consequence of their assumed prior commitment by immu-
nological hyperstimulation (Siegel and Morton, 1967). 
Similar observations have been done by other investigators. 
Ceglowski and Friedman (1968, 1969) noted the relationship be-
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tween susceptibility to the virus and immunodepression. They sug-
gested that the target cells for both leukaemogenesis and immuno-
genesis might be similar or related, leaving open the possibility that 
the common stem cell was involved. 
Seidel (!972) assumed that the changes in granulopoiesis and 
thrombocytopoiesis found during the erythroblastic phase of 
Rauscher leukaemia in BALB/ c mice are the expression of the leu-
kaemic involvement of a common stem cell. This would suggest that 
the pluripotent stem cell be the target of the virus. 
In conclusion, many data can be collected from the literature, 
which are indicative of, or at least compatible with the involvement 
of a primitive, possibly pluripotent haematopoietic cell in Friend and 
Rauscher disease. In addition, the virus might attack directly some 
differentiated cell types, like the megakaryocyte, as observed in elec-
tron microscopy (Rauscher 1962) or deduced from the early, dose-
dependent reduction of the platelet life span (Brodsky e.a., 1968) 
and presumably the normoblasts, as judged from the data presented 
by Reilly and Schloss (!971 ), who found Rauscher virus within cir-
culating erythrocytes as early as four days after virus inoculation. 
The sequelae of the settling of the virus in these differentiated cells 
are inconspicious in comparison with the effects of the transforma-
tion of more primitive precursor cells. The presence of the virus with-
in blood platelets and red blood cells might account in part for their 
shortened life span. On the other hand, the intrusion of the virus into 
a primitive haematopoietic cell could entail the proliferation and ac-
cumulation of immature cells, impeding the outpouring of function-
ing blood cells, which would result in the enlargement of spleen and 
liver, in the interference with vital functions and in a lethal outcome. 
The same principles ~ the proliferation and accumulation of im-
mature haematopoietic cells, the resulting enlargement of spleen and 
liver and an inadequate output of mature blood cells ~ characterise 
human (blastic) leukaemia. According to these criteria the murine 
leukaemia selected seems to be a good experimental model. 
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CHAPTER III 
MATERIALS AND METHODS 
Experimental animals 
All animals used in the experiments to be described were from 
inbred strains of mice, kept in this laboratory. 
I) Most experiments were carried out in BALB/c mice from an 
inbred strain obtained from the Charles River Breeding Laboratories, 
North Wilmington, Massachussets, U.S.A., as germfree animals in 
1967 and conventionalized in Rijswijk in 1968. The mice were ori-
ginally bred by Andervont in the National Cancer Institute. Bethes-
da, Maryland, U.S.A. 
2) C57BL/Rij mice; this strain was obtained in 1953 from Milhl-
bock, Amsterdam (origin: Little, Jackson Laboratories). 
3) Chromosome studies were done with CBA/T6T6 mice ob-
tained from Boranic (Zagreb, Jugoslavia) in 1966, as well as with F1 
hybrids of BALB/c x CBA/T6T6. As co-isogenic controls FJ hybrids 
of BALB/c x CBA/Rij were used in these experiments; the CBA/Rij 
mice were obtained from Milhlbock in Amsterdam in 1953 (origin: 
Bonser, Leeds). 
Mice were routinely kept in groups of 4 to 5 together in transpa-
rent polycarbonate cages. Food pellets and tap water were supplied 
ad libitum. For the irradiated animals the drinking water was 
acidified to pH 3 by adding HCI in order to inhibit bacterial growth. 
Virus 
The Rauscher Leukaemia Virus (RL V) used in these experiments 
was obtained in 1969 from the Netherlands Cancer Institute, 
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Amsterdam, to which it was provided in 1967 by Dr. F. Rauscher jr. 
from the National Cancer Institute, Bethesda, Maryland (U.S.A.). 
For the present studies virus preparations were made from a pool 
of frozen stored spleens of BALB/ c mice, infected with the virus. 
The spleens, weighing at least 800-1000 mg., were homogenized in an 
Omnimixer (Sorvall, type OM 1220) with 5 x their volume of Phos-
phate Buffered Saline (PBS); the homogenate was centrifuged for 15 
minutes at 6000 rpm in a conventional table centrifuge and the 
supernatant was collected. The pellet was homogenized in 5 x its 
volume of PBS. After centrifugation the supernatant was added to 
the first yield. This stock of RLV was divided in lots of 2-3 ml, 
frozen at ~2ooc and after one day stored in liquid nitrogen in glass 
ampoules or in sealed plastic tubing, until use. 
Histological techniques 
For histological examination the organs were fixed in Bouin's 
solution or in 4% buffered formalin, processed in an Autotechnicon 
2A (Technicon Company, Chauncey, New York, U.S.A.) and em-
bedded in paraffin. Sections of 5 J1 were cut and stained with hae-
matoxilin-phloxin-saffron. 
Cytology 
Spleen imprints and bone marrow smears on glass slides were 
stained with May-Grunwald-Giemsa stain. 
Haematology 
Blood was withdrawn under light aether anaesthesia by orbital 
puncture with a heparinized capillary haematocrit tube. After filling 
the haematocrit tube 4 to 5 drops of blood were collected in a plastic 
vial, containing a small amount of EDT A-powder for anticoagulation. 
One drop of blood was smeared on a glass slide for differential 
counts of the nucleated cells. For leukaemic blood better results 
were obtained with sedimentation preparations, prepared in the ap-
paratus devised by Sayk (1960) and modified by Bats (1963), using 
20% fetal calf serum as a suspension medium; the air-dried prepara-
tions were stained with May-Grunwald-Giesma stain. Haematocrits 
were read after centrifugation in a microhaematocrit centrifuge (In-
ternational model B, International Equipment Company, Boston 
Mass. U.S.A.). Nucleated cells were counted in a Coulter Counter, 
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Model A, (Coulter Electronics, St. Albans, Herts, U.S.A.) equipped 
with a I 00 11 aperture, after addition of 3 drops of Zaponin (Coulter 
Electronics, Dunstable, Beds, England) to I 0 ml of a dilution of the 
blood in Isoton (Coulter Electronics). Platelets were counted either 
in Biirker counting chambers under phase contrast microscopy ac-
cording to Brecher and Cronkite (1950) or in the Coulter Counter, 
equipped with a 30 11 aperture, as devised by Nakeff (to be 
published). 
Radiation 
The animals were irradiated with a Philips-Miiller M.G. 300 
(C.H.F. Muller GMBH, Hamburg, Germany) operated under the 
following conditions: 300 kV, I 0 rnA, beam H.V.L 3.0 mm Cu. The 
mice were exposed in a flat perspex box, maximally 20 at a time, at a 
distance of 50 em from the focus of the X-ray tube. Dose rate: 
60 rads per minute, measured with a dummy. 
Spleen colony assay 
Splenic stem cells were measured by the colony forming tech-
nique according to Till and McCulloch (1961 ). Spleen cell suspen-
sions were prepared by mincing the spleen with scissors in a watch 
glass with Hanks' solution and by pressing the fragments gently 
through double layer nylon gauze (van Bekkum and de Vries, 1967). 
Cell counts were performed in a haemocytometer after dilution with 
trypan blue solution to permit enumeration of the viable cells. The 
cell suspensions were kept at 0-40C until injection. Of each spleen 
cell suspension various concentrations were made in Hank's solution, 
ranging from JOS to I o6 cells per 0.5 mi. This amount of each sus-
pension was injected intravenously into the recipients under light 
aether anaesthesia. The recipients, I 0 weeks old female BALB/ c 
mice, pretreated with 700 rads whole body irradiation 1-4 hours 
previously, were sacrified I 0 days later. The spleens were fixed in 
Tellyesniczky's solution. Superficial colonies were counted with the 
naked eye. 
The number of colonies produced by I o6 spleen cells was cal-
culated for each dilution and the mean of these figures was referred 
to as the number of colony forming units (CFU). 
Background counts in simultaneously irradiated, non-injected 
control mice were negligible: less than one colony in 20 spleens. 
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For the histological evaluation of the cell types in the colonies, 
the spleens were processed as indicated above and sectioned semi-
serially. 
Chromosome analysis 
Chromosome analysis was performed by a modification of the 
method of Bunker (1965). 
The spleens were removed aseptically and cell suspensions were 
prepared. The cells were washed in sterile Hanks' solution, diluted to 
106-2.106 cells per ml in Hanks-Eagle medium containing 17% fetal 
calf serum and 4 Jlg colchicine per mi. These cell suspensions were 
incubated for 3 hours at 37oc in flat I 0 ml culture bottles. After the 
incubation, the cells were collected - both those in suspension and 
those sticking to the glass walls - and spinned down in a centrifuge 
tube (5 minutes at 1000 rpm). The supernatant was discarded and 
3 ml of a 0.91% tri-sodium citrate-2H20 solution, previously warmed 
to 37°C, was added. The cells were resuspended by gentle sucking 
and squirting through a wide-mouthed Pasteur pipette, incubated for 
15 minutes at 37°C and centrifuged again for 5 minutes at 800 rpm. 
The supernatant was discarded and 3 ml of a freshly prepared 
fixative was added (acetic acid I part, methanol 2 parts). The tube 
was left at room temperature for I 0-15 minutes, centrifuged again 
for 5 minutes at 800 rpm and approximately I ml of fresh fixative 
was added. 
Squash preparations were made by dropping the cells suspended 
in the last change of fixative on cleansed glass slides just dipped in 
25% aethanol. The slides were flamed briefly, air-dried, fixed in 
methanol and stained for I 0 minutes with Giesma stain. 
Preparation of antiserum 
Virus particles were isolated from the plasma of infected mice on 
a continuous sucrose gradient of 5 to 20%, according to the device of 
Chenaille e.a. ( 1968). From each of 3 tubes of the gradient the band 
containing the virus particles was harvested and suspended in 3 ml of 
Tris-buffer. Complete Freund adjuvant was added until the mixture 
emulsified and then the emulsion was injected intramuscularly into a 
2 kg rabbit. Two weeks later the procedure was repeated with incom-
plete Freund adjuvant. Four and six weeks later purified virus was 
injected without adjuvant. Two weeks after the last injection the 
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serum of the rabbit was tested and if the titer was sufficient the 
animal was bled. 
The serum was tested by precipitation of virions in the double 
diffusion plate technique of Ouchterlony, performed by Dr. Bent-
velzen. Radiobiological Institute TNO, Rijswijk. 
Incubation of spleen cells with antisera 
One to 15 ml of serum and an equal volume of a cell suspension 
containing 10 7 cells per ml were incubated for 45 minutes at 37°C; 
every 10 minutes the cells were resuspended by gentle shaking. 
Thereafter, the suspensions were diluted with Hanks Balanced Salt 
Solution to the desired concentration. 
Absorption of antiserum with normal mouse spleen cells 
Equal volumes of rabbit serum and cell suspensions containing 
1 o7 cells per ml were incubated for 45 minutes at 37°C; the cells 
were repeatedly resuspended by gentle shaking. 
After incubation, the suspensions were centrifuged for 15 min-
utes at 2000 rpm in a table centrifuge; the supernantant was har-
vested and used as absorbed antiserum. 
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CHAPTER IV 
NATURAL IDSTORY OF RAUSCHER DISEASE 
As a point of departure for all further experiments and to allow a 
comparison with results presented by others, an orientating study of 
the natural history of Rauscher disease was carried out in two strains 
of mice kept in this laboratory and infected with the virus available. 
Virtually all BALB/ c mice receiving a high dose of the Rauscher 
Leukaemia Virus (RL V) preparation at the age of 4 weeks responded 
with a rapidly developing splenomegaly, a deterioration of the 
general condition, as manifested by a hunched back, shaggy fur, 
pallor and stunted growth. Mortality was higher after the third week 
of infection. 
Neonatally infected C57BL mice became leukaemic only after 
several months. Details are described below. 
A. Studies in BALB/c mice 
1. Survival 
To study the survival of mice infected with RLV, 30 female 
BALB/c mice, aged 4 weeks, were inoculated i.p. with 0.2 ml of the 
undiluted RLV-extract and kept in groups of 5 mice per cage. The 
dead animals were removed and the survivors recorded daily. The 
results are depicted in Fig. L 
As can be seen from the curve, 50% of the infected mice died 
during the fourth week; 90% of the animals died before the 37th 
day. 
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Fig.l. Survival of BALB/c mice infected with Rauscher Leukaemia 
Virus (RLV). 
2. Pathology 
In the animals autopsied after spontaneous death some yellowish 
or reddish fluid was often found in the peritoneal cavity; large 
amounts of blood were rarely seen unless the fragile spleen had been 
damaged during the autopsy. Rupture of the spleen appeared not to 
be a frequent cause of death, in contrast to the statement of Siegler 
(1968). 
A systematic study was undertaken to follow the evolution of the 
pathology of Rauscher disease from infection until the terminal 
stages. An experimental group and a control group were studied 
simultaneously. 
a) 24 BALB/ c mice, 4 weeks of age, were inoculated intra peritoneal-
ly with 0.3 ml of the undiluted RLV-extract and divided into 6 
groups, kept separately in numbered cages, four animals per cage. 
Twice a week a group of 4 animals was sacrificed in the order of the 
cage number. 
b) 24 uninfected BALB/c mice of the same age as the preceding 
group were kept together in a large-size cage and twice a week 4 
animals were taken at random and sacrificed. 
The mice were killed by cervical dislocation. Before sacrifice 
blood was withdrawn under aether anaesthesia by orbital puncture 
for haematological investigation. The organs were inspected in situ 
and the spleen was removed and weighed. A piece of the liver, the 
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thymus, a kidney, the sternum and one or more axillary, inguinal or 
mesenteric lymph nodes were collected for histological examination. 
Imprints were made of the cut surface of the spleen and the femoral 
bone marrow was smeared on microscope slides for cytological 
examination. 
The spleen 
The most impressive morbid changes in the course of Rauscher 
disease were seen in the spleen and in the liver. From day 7 onwards 
the spleen weight increased almost exponentially until a weight of 
approximately 3 grams was reached after 3 to 4 weeks (Fig.2). The 
enormous spleen weights reported by Rauscher (1962), amounting to 
6 grams, were never attained in these mice. Initially, the spleen tissue 
spleen weighllmgl 
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Fig.2. Spleen weights of BALB/c mice after infection with Rauscher 
Leukaemia Virus (RLV). 
had a firm, homogeneous consistence and a greyish colour, but 
during the third week multiple haemorrhages appeared. Only rarely a 
spleen of more than 2 grams was encountered without macroscopic-
ally visible haemorrhages; most heavy spleens were swollen by large 
blood-filled spaces, bulging the tightly stretched splenic capsule. A 
slight injury to this thin capsule caused its rupture and the extrusion 
of a considerable quantity of bloody fluid, amounting to a few milli-
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liters, comparable to the total circulating blood volume of a normal 
mouse. It is understandable that minor traumata may rupture such a 
spleen and cause the death of the animal (Siegler 1968). 
Microscopically, an increase in haematopoiesis was seen in the 
spleen as early as 4 days after RLV injection. Both granulopoiesis 
and erythropoiesis appeared more active than in the normal control 
spleens. Many megakaryocytes could be found in the spleens of the 
RLV-infected mice. After the first week of infection the lymphatic 
tissue of the spleen was gradually displaced by erythropoiesis, re-
presented by erythroblasts in various stages of maturation. The 
majority of the cells were very young and almost undifferentiated 
(reticulum) cells. Only few mature orthochromatic normoblasts were 
present. The granulopoiesis, too, remained active, as manifested by 
the presence of groups of myeloblasts, myelocytes and mature neu-
trophils. However, after the 18th da,y from RL V inoculation the 
spleen appeared to be occupied largely by erythroblasts in all stages 
of development. Little was left of the preexisting lymphatic struc-
tures of the spleen; only few small lymphocytes could be detected in 
the remnants of the white pulpa. In occasional fields foci of poly-
morph young lymphoid cells were encountered up to the fourth 
week. In later stages of the disease haemorrhages became conspicious 
in the majority of the spleens. The borders of these haemorrhages 
sometimes showed signs of fibrosis. 
The liver 
The liver increased gradually in size and acquired a greyish tinge. 
Finally its consistence became firm and rigid, apparently due to its 
infiltration by foreign cells. 
Microscopically, one week after RLV-injection small clusters of 
myelocytes and erythro blasts were seen in the portal triads. Also a 
few megakaryocytes were found, but these were present in the con-
trol livers as well. The haematopoietic infiltration proceeded steadily 
and in the fourth week after infection not only the portal triads, but 
also the liver sinusoids and the central veins were stuffed with ery-
throid cells, displacing the liver parenchyma. Occasional foci of 
granulopoiesis could be discerned even in terminal stages. 
The bone marrow 
The changes in the bone marrow were on the whole less dramatic 
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than in the spleen and in the liver. Initially, the granulopoiesis ap-
peared to be stimulated and increased in proportion to the erythro-
poiesis. Even up to three weeks after RLV-infection a varying degree 
of myeloid hyperplasia was evident. In the fourth week the erythro-
poiesis usually became preponderant and from day 28 onwards the 
erythroblasts crowded the bone marrow, replacing other cell types. 
However, both myelocytes, neutrophils and megakaryocytes re-
mained present in the bone marrow until death. 
Other organs 
Thymic enlargement was never found in the RLV-infected 
BALB/c mice, neither in this series nor in subsequent experiments. 
This finding is in contrast to the experience of Siegler and Rich 
(1964) in Swiss ICR mice, infected either with Friend virus or with 
Rauscher virus. Microscopically, we found only slight changes in the 
thymus: in the cortex of the lobules lymphoblasts were present with 
numerous mitotic figures. 
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The lymph nodes were not enlarged at any time after RLV in-
fection in our mice. In the histological sections the normal architec-
ture of the lymph nodes was preserved. The centres of the follicles 
appeared to be active during the entire course of the disease. 
Apart from the pallor due to the anaemia, the examination of the 
other organs including the kidney did not reveal any conspicious 
pathological changes, neither macroscopically nor microscopically. 
3. Haematology 
The results of the measurement of the haematocrit, the nucleated 
cell counts and the platelet counts of the same series of animals are 
reported in Table I. 
The haematocrit remained constant until approximately l-2 
weeks after the infection with RLV, and then slightly decreased. 
Though not apparent from this particular experiment, in the terminal 
stages most animals became severely anaemic (see e.g. Table H). 
The total nucleated cell count showed a slight dip in the first 
week, followed by a quick rise to extremely high values preterminal-
ly (Fig.3). As judged from the peripheral blood smears, this rise in 
nucleated cells was mainly due to an increase in the number of 
lymphocytes (Fig.4A). In some cases the liberation of large numbers 
of nucleated red cells from the haematopoietic tissues, presumably 
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Fig.3. Nucleated cell counts in the peripheral blood of BALB/c mice 
after infection with Rauscher Leukaemia Vuus (RLV). 
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Fig.4. Peripheral blood of BALB/c mouse infected with Rauscher Leukaemia Virus 18 days 
previously. 
A. lymphocytes and large mononuclear cells (MGG x 800) 
B. nucleated red cells (MGG x 450). 
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Fig.5. Peripheral blood of BALB/ c mouse infected with Rauscher Leukaemia Virus. 
A. large mononuclear cells 14 days after virus inoculation (MGG x 1650) 
B. distorted red cells 21 days after virus inoculation (MGG x 800). 
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the spleen, accounted for a substantial contribution to the total 
nucleated cell count (Fig.4B). Especially in these cases many dis-
torted erythrocytes were seen, resembling the schistocytes and burr-
cells of human microangiopathic haemolytic anaemia or disseminated 
intravascular coagulation (Fig.5B). 
In the second week after RL V many large mononuclear cells were 
discernable in the peripheral blood, characterized by a big round or 
oval nucleus with a loose chromatin structure and abundant clear 
blue cytoplasm, sometimes containing a few purple granules 
(Fig.5A). In subsequent smears these cells were not detected in ap-
preciable numbers. Perhaps these cells are the same as those 
described by Hopkins and Siegel (1965) who regarded them patho-
gnomonic for virus-induced leukaemias. Since these cells disappeared 
in the course of the disease they must probably be regarded as sti-
mulated lymphocytes, inherent to the viral infection and should not 
be regarded as typical Rauscher leukaemia cells. 
The platelet count dropped in this series to approximately I 0% of 
the initial value, the decrease starting in the second week (Fig.6). The 
occurrence of splenic haemorrhages might in part be due to the 
severe thrombocytopenia. However, haemorrhages usually were not 
found at other sites in the leukaemic mice, even when sacrificed 
moribund. 
tt-ro"rtlocytes (x 1:? II) 
• 
• 
• 
• 
100 • 
• 
50 
• 
20 
o+-----.-----r----.-----.---------------
0 7 14 21 28 days after RLV inoculation 
Fig.6. Platelet counts in the peripheral blood of BALB/c mice after infection 
with Rauscher Leukaemia Virus (RLV) 
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Conclusions 
From the observation of the natural history of Rauscher disease 
in BALB/c mice the following conclusions may be drawn: 
I) In BALB/ c mice Rauscher virus induces erythroblastosis with ac-
cumulation of immature cells of the erythroid series in the spleen, 
the liver and eventually in the bone marrow, accompanied by anae-
mia, thrombocytopenia and general deterioration, culminating in 
death. 
2) Splenic rupture was not the common cause of death. 
3) Granulopoiesis in BALB/ c mice remained active throughout the 
course of the disease; there were, however, no indications of myeloid 
leukaemia as reported by Boiron e.a. ( 1965) and by Seidel ( 1971 ). 
4) Lymphatic leukaemia was never seen in BALB/ c mice, although 
sometimes very high lymphocyte counts were found in the peripheral 
blood; this is in agreement with the experience of Boiron e.a. (I.e.). 
5) Thrombocytopenia could not be attributed to a lack of mega-
karyocytes, neither in the early nor in the later phase of the disease, 
as has been concluded by Brodsky e.a. (1968) from their observa-
tions. 
B. Influence of the dose of RL V 
The incubation period of a viral disease is the time required for 
the multiplication and spread of the virus in the infected individual 
until so many cells are involved that signs of the disease become 
manifest. High doses of virus, therefore, need a shorter period of 
latency than lower doses, provided that a greater number of target 
cells are attained by the larger inoculum. For Rauscher disease this 
was checked in the following experiment: 
30 BALB/c mice, 4 weeks of age, were infected by i.p. injection 
of 0.2 ml of the undiluted virus extract; in a parallel series of 30 mice 
of the same strain and age 0.2 ml of a J0-1 dilution of the extract 
was injected. At day 3, 7, 10, 14, 17 and 21, groups of 4 mice of 
each series were sacrificed after withdrawal of blood for cell counts, 
and their spleens were weighed. 
Dilution of the virus preparation to I o-2 and I o-3 resulted in very 
long incubation periods, making systematic studies unfeasible. Still 
smaller amounts of virus seemed to cause no detectable leukaemia at 
all. 
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Results: By a I O-f old dilution of the virus the onset of splenome-
galy was delayed for ± 7 days (Fig. 7). The doubling time of the 
spleen weight was slightly shorter for the higher than for the lower 
dose: ± 3.5 days respectively. The rise of the peripheral nucleated 
cell count was delayed for a few days by the dilution of the virus-
preparation (Fig.8). The same phenomenon was observed in the 
changes of the platelet counts (Fig.9). 
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Fig.7. Spleen weights of BALB/c mice after infection with the un-
diluted and a 10-fold diluted preparation of RLV. Each point 
represents the mean of 4 spleens; standard deviation indi-
cated by vertical bar. 
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Fig.8. Nucleated cell counts in the peripheral blood of BALB/c 
mice infected with an undiluted and a 10-fold diluted prepa-
ration of Rauscher Leukaemia Virus (RL V). Each point re-
presents the mean of 4 mice. 
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Fig.9. Platelet counts in BALB/c mice after infection with an un~ 
diluted and a lO~fold diluted preparation of RLV. Each 
points represents the mean ±S.D. of 3-4 mice. 
Conclusions: The delayed onset of splenic growth suggests that 
less target cells are affected by the smaller inoculum of virus and that 
multiplication of virus and subsequent infection of more target cells 
before the overt manifestations of the disease occur, rather than the 
proliferation of a fixed number of transformed cells from the outset. 
It is not clear why the splenic enlargement is delayed for a longer 
period than the changes of the platelet and nucleated cell counts. 
Perhaps, the number of test animals was too small to attach much 
importance to the difference. 
C. Rauscher leukaemia in C57BL mice 
Boiron e.a. (1965) have shown that the same Rauscher virus pre-
paration can induce erythroblastosis in BALB/c mice and myelo-
blastic leukaemia in C57BL mice. In contradistinction, Ishimoto and 
Maeda ( 1970) describe only lymphomas in this strain of mice after 
infection with Rauscher virus. 
To compare our virus with that used by the cited authors, a litter 
of C57BL mice was infected neonatally with RLV by intraperitoneal 
injection. The animals were kept together and sacrificed when organs 
became palpably enlarged. Eventually 6 mice could be evaluated, 
respectively 183, 197,270 en 291 days after infection. 
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Results: Surprisingly, three different types of leukaemia were en-
countered: 
1) Two mice were sacrificed 183 days after infection because ab-
dominal masses could be palpated. The leukocyte count was 
80 x 1 o9 /1.; in the peripheral blood smear mature granulocytes 
predominated: 84%; young myeloid cells B>%, lymphocytes 6%, 
monocytes 2% and smudge cells 6\>%. Haematocrit 37.5%. Besides 
the splenomegaly there also was an enlarged liver and a large 
mesenteric lymph node. Other lymph nodes were only moderate-
ly enlarged; the thymus was normal in size. The cut surface of the 
abdominal "lymphoma" was yellowish-green; the imprints 
showed predominantly mature granulocytes. Granulocytic in-
filtrations were seen in other lymph nodes and in the liver. The 
bone marrow was hypercellular and here, too, mature granulo-
cytes prevailed. Remarkably, many megakaryocytes were found 
among the granulocytes in all organs. The disease should be clas-
sified as a chloroma-like granulocytic leukaemia. 
2) Two mice sacrificed 197 days after the infection presented with 
splenomegaly, hepatomegaly, generalized lymph node enlarge-
ment and a huge thymus. The peripheral leukocyte counts were 
30 and 106 x 1 o9 /1 consisting virtually entirely of lymphocytes. 
Lymphocytes, too, were the sole cell type in lymph nodes and 
thymus; the liver was heavily infiltrated with lymphocytes and in 
the spleen these cells predominated as well. Obviously, these 
animals had a lymphatic leukaemia. 
3) The animals sacrificed at day 270 and 291 had splenomegaly, 
hepatomegaly and mesenteric lymph node enlargement. The 
thymus seemed to be normal. The blood picture was character-
ized by a leukocytosis with many immature granulocytes. The 
enlarged organs were stuffed with the same type of young mye-
loid cells, mainly myelo blasts and promyelocytes. Besides, in the 
spleen many foci of erythroblasts were seen. 
These animals had a myeloid leukaemia, but differing from that 
observed in the first group of mice with respect to the immaturity 
of the cell population. 
Conclusion: Although an exhaustive analysis could not be carried 
out an important conclusion might be drawn from these observa-
tions, viz. the ability of RL V to induce granulocytic leukaemia in 
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C57BL mice. It is not warranted to ascribe the lymphatic leukaemia 
observed in two mice in this series to the injected virus, because 
lymphatic leukaemia is a naturally occurring disease in this strain of 
mice. In BALB/c mice, however, lesions comparable to those in the 
C57BL mice suffering from granulocytic leukaemia never were 
found. This is an argument against the leukaemic nature of the neu-
trophilia and the myeloid hyperplasia found in the erythroblastic 
phase of Rauscher disease in BALB/ c mice. 
D. Rauscher disease in splenectomized mice 
Dunn and Green (1966) noted an intensification of the hepatic 
involvement in erythroblastosis if BALB/c mice were splenectomized 
prior to RLV infection. Erythroblast foci were also found in lymph 
nodes. 
Yokoro and Thorell (1966) studied Rauscher disease in splenec-
tomized mice of a different strain of mice (NMRI). They demon-
strated that the development of a leukaemic blood picture and 
hepatomegaly could not be prevented by splenectomy. The progres-
sion of the erythroblastosis appeared to be Jess fulminant than in in-
tact animals and early mortality due to splenic rupture was of course 
eliminated. 
To study the role of the spleen in the natural history of Rauscher 
disease in BALB/c mice a group of 6 mice was infected with the virus 
immediately after splenectomy had been performed at the age of 5 
weeks. In all animals the leukocyte count and the haematocrit were 
followed until death occurred spontaneously. A group of 6 non-
splenectomized mice served as controls. Blood was withdrawn 
bi-weekly by cutting the tail under aether anaesthesia; histology of 
the dead animals was performed routinely. 
Results: The most striking differences between the two groups 
(Table II) were seen in the rate of development of a leukaemic blood 
picture and in the survival time. The extensive liver involvement was 
also a feature of the splenectomized mice; presumably this depended 
on the protracted course of the disease, allowing the leukaemic infil-
tration to proceed in this organ. 
In both groups the haematocrit might have been influenced by 
the repeated withdrawal of blood from each animal, the more so as 
in some animals the tail wound bled profusely. Nevertheless, after a 
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Table II. Mean values of nucleated cell counts and haematocrit measurements of splenecto-
mized BALB/c mice infected with RLV compared with non-splenectomized con-
trol mice, infected at the same time. 
Intact Splenectomized and 
infected controls infected mice 
Day after Nucleated cells Haemotocrit Nucleated cells Haemotocrit 
infection (x106/l) (%) (x 106/1) (%) 
4 9,700 39.5 15,400 ----
7 8,000 40.3 11,400 37.4 
11 6,600 35.0 6,780 35.8 
18 70,300 26.1 8,980 31.8 
21 42,800 29.0 12,800 27.4 
25 17,000 26.5 10,300 23.3 
28 10,900 23.1 
32 21,000 26.4 
35 59,120 25.9 
39 121,000 22.5 
46 124,100 26.0 
53 209,000 27.5 
60 171,000 29.0 
67 286,000 33.5 
74 146,000 ----
severe drop in the haema tocrit in the splenectomized mice in the first 
three to four weeks the animals seemed to recuperate from the anae-
mia to a certain extent. Independently, the total nucleated cell count 
rose steadily, probably reflecting the proliferation of leukaemic cells 
in the haematopoietic organs. At postmortem examination of the 
splenectomized mice especially the enormous liver was striking, in-
vaded by greyish-white leukaemia tissue. The other organs were not 
invaded by tumour cells. The thymus was not enlarged. 
Microscopical examination of the liver confirmed the extensive 
infiltration of the foreign cells in the liver parenchyma. Sinusoids, 
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central veins and portal tracts were crowded with primitive cells, 
resembling those seen in the non-splenectomized mice, in addition to 
more differentiated erythroblasts. 
The bone marrow appeared to be crowded with cells; both ery-
thropoieses and myelopoiesis were abundant and megakaryocytes 
were present as welL Apart from some fields containing many young 
myeloid elements, the maturation of the different cell lines seemed 
to be normaL Especially in the cytological preparations the number 
of lymphocytes was striking. 
Conclusions: From these experiments the following conclusions 
may be drawn: 
I) the presence of the spleen is not essential for the induction of 
erythroblastosis in mice, although in splenectomized mice it takes 
more time for the virus to kill the host; 
2) in the absence of the spleen the tumour cells accumulate pre-
ferentially in the liver; 
3) the presence of large masses of tumour cells in the liver sinusoids 
is independent of the presence of the spleen; these cells are not 
necessarily transported from there to the liver, as has been argued by 
Siegler (1968); 
4) the haematocrit does not reflect the growth of the leukaemic cell 
mass, which is an argument against the hypothesis of Brodsky e.a. 
(1969) who associate the changes in the ferrokinetics with the pro-
gression or regression of Rauscher erythroblastosis. 
D. The role of the bone marrow 
The development of Rauscher erythroblastosis in mice without 
spleens indicates that target cells for the virus are present in other 
organs, as welL Thomson (1969) and Yokoro e.a. (1966) have sug-
gested that bone marrow cells are affected primarily by the erythro-
blastosis virus. 
Lethal irradiation prevents the replication of erythroblastosis 
virus by the eradication of haematopoiesis (Axelrad and Steeves 
1964). Extracellular virus is rapidly inacticated at body temperature, 
so that propagation of infection must result from virus replicated 
within target cells of the host. Shielding of part of the haemato-
poietic organs during otherwise lethal irradiation may preserve 
enough target cells for the virus to secure its survivaL 
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In the following experiment one hind leg of BALB/ c mice was 
shielded during irradiation with an otherwise lethal dose in order to 
investigate the presence of target cells in the bone marrow. 
40 BALB/ c mice, I 0 weeks of age, were irradiated after anaesthe-
sia with nembutal. One hind leg was shielded for part of the irradia-
tion period so as to reduce the dose of radiation to the extremity to 
100-500 rads whereas the remainder of the body received 700 rads. 
The same day 0.2 ml of undiluted RLV extract was injected intra-
peritoneally. After 21 days the mice were killed and their spleens 
weighed. 
Results: The mice developed splenomegaly which varied inversely 
to the dose of radiation delivered to the hind leg (Fig. I 0). 
spleen weight 
400 (mgl (10} 
300 (8} I I 
200 (5} I 100 (3} I 
0 
500 400 300 200 
dose of radiation to one leg (reDs) 
Fig.lO. Spleen weights, measured 21 days after whole body irradia-
tion with shielding of a hind limb and subsequent infection 
with RLV. Number of mice in each dose-group indicated 
between brackets. Vertical bars= standard deviation. 
Conclusion: The fact that splenomegaly developed in these 
animals in spite of the irradiation of the liver and the spleen con-
firmed that the virus may meet its target elsewhere, apparently in the 
bone marrow. Presumably, these infected cells migrate to the spleen 
and the liver. 
The negative correlation between the dose of radiation received 
by the bone marrow and the size of the spleen 21 days later suggests 
that the target cells for the virus are sensitive to irradiation, which 
prevents the replication of the virus, or that the splenomegaly 
depends on the number of cells capable of migrating to the spleen, or 
both. 
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F. Transplantation studies 
In contrast to the lymphocytic leukaemia induced by Rauscher 
(1962), the initial erythroblastic disease induced by the same virus 
cannot be transplanted in the classical sense, i.e. by continuous pro-
liferation of the transferred cells. If viable cells of the enlarged ery-
throblastic spleens are injected subcutaneously into uninfected mice 
of the same strain, typical Rauscher disease ensues, which, however, 
seems to be virus-born and not caused by proliferation of trans-
planted cells. The incubation time is similar to that observed after 
virus injection, no local growth can be seen at the site of deposition 
of the cells and the disease starts in the spleen and is restricted to the 
haematopoietic organs, mainly the spleen and the liver, just like the 
primary, virus-induced disease (Dunn e.a. 1966). 
Although these transplantation studies have been carried out in 
syngeneic mice, the possibility of an immunologic rejection of the 
transplanted cells has to be considered notwithstanding the impaired 
immune system in Rauscher virus-infected mice (Siegel and Morton 
1966, Hiiyry e.a. 1970). Virus-induced antigenic alterations of the 
cellular surface might behave as transplantation antigens, which 
might elicit an immunological response in the host, severe enough to 
kill the cells bearing these antigens. 
An alternative possibility for the disappearance of the local de-
posits of subcutaneously injected leukaemic spleen cells might be the 
maturation and transportation of the cells. In this case the splenic 
onset could be explained by the migration of stem cells to the spleen. 
To rule out these possibilities the following experiments were carried 
out. 
I. To exclude the possibility of a potent new histocompatibility 
antigen present upon the membrane of the spleen cells of Rauscher 
virus-infected mice, transplantation of these cells was performed to 
sublethally irradiated mice. One year old recipients were selected 
because they were thought to be less susceptible to the virus than 
younger mice. 
Five female BALB/ c mice, one year of age, received 200 rads 
whole body irradiation. The same day approximately 108 leukaemic 
spleen cells were injected subcutaneously into the neck region. The 
mice were observed until leukaemic. 
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Results: The first mouce died spontaneously 32 days after the 
spleen cell transplantation with a grossly enlarged spleen; no local 
tumour could be found. The other test animals were sacrificed 7 
weeks after the transplantation, because in all an enlarged spleen 
could be palpated. In the neck region local tumours could not be 
palpated throughout the observation period. Dissection of the site of 
injection revealed no foreign cell deposits. The spleens were mas-
sively enlarged and the microscopic aspect of the spleen, the liver 
and the other organs was similar to that of virus-infected younger 
animals. 
Conclusion: Assuming that the sublethal irradiation was a suffi-
cient immunosuppression for the virus-infected mice, the absence of 
local growth of transplanted leukaemic spleen cells cannot be 
ascribed to virus-induced histocompatibility antigens. In this experi-
ment migration of cells to the spleen and liver and proliferation of 
transported cells within these organs could not be excluded. There-
fore a comparable experiment was carried out with the use of a 
chromosome marker to permit the determination of the origin of the 
proliferating spleen cells in the leukaemic recipients. 
II. In order to rule out the possibility that the transferred leukaemia 
was due to the migration of transplanted stem cells into the haemato-
poietic organs of the recipients, in the present experiment the spleen 
cells were injected intravenously in maximally immunodepressed 
animals (350 rads whole body irradiation). A donor-recipient com-
bination was selected which differed only in the presence of a marker 
chromosome. The FJ hybrids of BALB/c x CBA/T6T6 were shown 
to be susceptible to the Rauscher virus; splenomegaly developed in 
these mice like in BALB/ c mice. 
Cell suspensions were prepared of three enlarged spleens, weigh-
ing 800-1000 mg, obtained from BALB/c mice infected with RLV 14 
days previously; 106 viable cells were injected intravenously into 
female F 1 (BALB/ c x CBA/T6T6) mice, who had received 350 rads 
whole body irradiation. The mice were observed until the spleens 
were palpably enlarged. 
After an interval of 46 days spleens were palpable and three mice 
with spleen weights of 500-900 mg were sacrificed. The chromosome 
constitution of the spleen cells was determined (Fig. II). 
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recipient: BALB/c x CBA/T6T6 donor: BALB/c 
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Fig.ll. Transplantation of leukaemic cells into sublethally irradiated co-
isogenic recipients with a different chromosome pattern. Experimen-
tal design for the determination of the origin of the proliferating 
spleen cells by chromosome analysis. 
Results: In the squash preparations a total of 58 meta phases were 
suitable for analysis. In each of these 58 metaphases the T6-marker 
could be recognized (Fig.l2). 
Fig.l2. Metaphase showing T6 marker chromosome (arrow) in spleen cell of 
female F 1 (BALB/ c x CBA/T6T6) in which leukaemia developed after 
injection of leukaemic spleen cells of BALB/c mouse. 
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Conclusion: The cells in mitosis must have been derived from the 
recipient and not from the donor, whose cells had a normal karyo-
gram without chromosomal marker. 
III. The presence of a minority of donor cells within the recipient 
spleen could not be excluded. For this reason the experiment was 
repeated, slightly modified: donors were FJ hybrids of BALB/c x 
CBA/T6T6, infected with a low dose of virus (0.3 ml w-1 dilution 
i.p.) at the age of 13 weeks and sacrificed II weeks later when the 
spleens were very large. Spleen cell suspensions were made and 
washed in Hanks BSS to remove excess virus. After centrifugation 
the supernatant was discarded and the pellet resuspended in Hanks' 
BSS to a concentration of 2.5 x 108 cells/mi. Of this cell suspension 
0.5 ml was injected in 6 F1 hybrids of BALB/c x CBA/Rij, which 
had been irradiated with 350 rads whole body irradiation one day 
before. Each recipient received 1.25 x 108 cells i.p. Two month later 
chromosome analysis was performed of the spleen cells of 4 recipient 
mice with splenomegaly. 
Results: Many metaphases were present in the squash prepara-
tions; 100 metaphases containing 40 chromosomes were screened for 
the presence of a T6 marker chromosome. This was detected in 6 out 
of I 00 metaphases. 
Conclusion: The fact that only 6% of the metaphases was of 
donor karyotype indicates that more than 90% of the proliferating 
spleen cells consisted of secondarily infected host cells. Only a small 
number of donor cells contributed to the splenomegaly. The bulk of 
the injected cells had disappeared. It may be concluded, that the 
majority of the cells in the leukaemic spleens are not capable of 
sustaining an autonomous proliferation upon transplantation, even in 
immunosuppressed syngeic or co-isogenic recipients. By inference, 
the leukaemic cell population in the primary infected animal is prob-
ably not self-maintaining. Presumably, a constant influx of newly 
recruited precursor cells is needed to preserve or - a fortiori - to 
increase the number of leukaemic cells and to produce splenomegaly. 
The primitive erythroid cells populating the spleen and the liver of 
the leukaemic animals either mature without multiplication or divide 
slowly after transplantation into sublethally irradiated recipients so 
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that mitoses belonging to the transplanted leukaemic cell population 
could not be found. 
If sufficient stem cells are present in the inoculum the appearance 
of the progeny of these stem cells in the haematopoietic organs -
and in the chromosome preparations - can be anticipated. The 
donor karyotypes detected among the spleen cells of mice, which 
received 108 leukaemic spleen cells presumably are derived from 
injected stem cells. The leukaemia thus is not transplanted in the 
common sense, but rapidly propagated by spread of the virus in the 
haematopoietic tissue of the recipient. 
The influence of erythropoietin on the evolution of Rauscher ery-
throblastosis 
Endogenous erythropoietin production is depressed by hyper-
transfusion. To evaluate the influence of erythropoietin on the 
splenogemaly of Rauscher erythroblastosis packed red blood cells 
were injected intraperitoneally in BALB/ c mice before and after in-
oculation with RLV. Assuming that the observed effects were due to 
the depression of erythropoietin levels, it was attempted to abrogate 
these effects by the administration of exogenous erythropoietin. 
A control group of I 0 BALB/ c mice and three experimental 
groups of 5 animals each received RLV at day 0. Packed cells were 
given either 6 and 3 days before or 2, 4 and 7 days after the infec-
tion. 
Erythropoietin (Anaemic sheep erythropoietin, step III, Con-
naught, Toronto) was administered in experiment III by intraperito-
neal injection of 5 U per mouse at day 8, I 0 and 12. 
The experimental set up is depected in Figure 13. 
Results: As is shown in Table III, the results suggest that the 
development of splenomegaly could be impeded by blood transfu-
sions, whether given before or after the infection with RLV and that 
erythropoietin promoted the splenic growth in mice in which the 
splenomegaly was previously retarded by blood transfusions. 
Conclusions: Theoretically, if measures applied to the recipient 
animals before the injection of RLV influence the course of the 
subsequent disease, their action could be attributed to the change in 
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Fig.13. Schematic representation of the experiments performed in order to 
investigate the influence of blood transfusions and erythropoietin on 
the spleen weight 21 days after infection with RLV. 
Table III. The influence of hypertransfusion before (experiment 1), 
and after (experiment II) infection with Rauscher leukaemia 
virus upon the spleen weight; cf. fig.13. 
Spleen Weight (mg) 
day 8 day 21 
Controls 202 + 75' 2156 + 402' 
- -
Exp. I 699 + 575' 
-
Exp. II 1169 + 796' 
-
Exp. Ill 1662 + 501' 
-
* mean + S.D. 
the number of target cells available for the virus. Thus, hypertrans-
fusion of mice before the inoculation with RLV might inhibit the 
splenic enlargement by the decrease of the number of early erythro-
blasts which are present at the moment of infection. Indeed, this was 
suggested by Pluznik e.a. ( 1966), who found a lower number of 
virus-induced spleen foci if blood transfusions were given to the 
recipients before the virus. 
An alternative explanation is provided by the assumption that the 
effect of the hypertransfusion lasts longer than the few days between 
the injection of blood and the inoculation of virus. Presumably, the 
hypertransfusion will depress the production of endogenous erythro-
poietin for some more days. This might interfere with the recruit-
ment of differentiated erythroid cells during the first few days after 
the virus inoculation, preventing the formation of virus-induced foci 
and the subsequent enlargement of the spleen. 
The validity of this hypothesis is strengthened by the observed 
effect of the blood transfusions administered after the inoculation of 
RL V. Thus, it is possible to influence the course of Rauscher disease 
even after the virus had reached its target. Dunn e.a. (1966) could 
prolong the survival of RLV-infected BALB/c mice for several 
months. The last experiment (Ill) in our series indicates that this 
inhibitory effect of blood transfusions can be neutralized by the 
administration of exogenous erythropoietin. The erythroblastosis 
thus appears to be hormone-dependent. 
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CHAPTER V 
THE STEM CELL IN RAUSCHER ERYTHROBLASTOSIS 
From the available literature no defmite conclusions could be 
drawn about the involvement of the pluripotent stem cell in 
Rauscher Leukaemia. In this study, therefore, efforts were made to 
perform a quantitative estimation of the number of splenic stem cells 
by the spleen colony assay of Till and McCulloch ( 1961 ), to check 
the functional integrity of the stem cells, and to look for the pre-
sence of virus within the pluripotent stem cell. 
Stem cell assay 
In lethally irradiated mice erythroblastosis virus survives only 
shortly and no spleen foci are formed (Axelrad and Steeves, 1964). 
The virus injected together with the leukaemic spleen cell suspen-
sions will not exert influence upon the colony assay by adding virus-
induced foci which might resemble spleen colonies. In the following 
experiment this was confirmed. 
In 4 groups of I 0 female BALB/ c mice, I 0 weeks of age, irradi-
ated with 700 rads, dilutions of a normal spleen cell suspension were 
injected without and with RLV. For this purpose two suspensions of 
normal spleen cells were prepared containing 2 x 105 and 5 x 105 
cells per 0.5 mi. Just before the injection of these suspensions into 
the irradiated recipients, to one half of each suspension RLV was 
added to a final concentration of 10-l. Each group of mice received 
either 2 x 105 or 5 x 105 spleen cells with or without RLV. Spleen 
colonies were counted after I 0 days. Because many mice died spon-
taneously before the tenth day, the experiment was repeated. The 
results of both series are given in Table IV. 
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Table IV. Spleen colony assay of normal spleen cell suspensions without and with the 
addition of RLV in vitro. The results of two separate experiments ("a" and "b") 
are reported; n =number of spleens in which colonies have been counted. 
Number of cells injected Number of colonies counted 
without and with RLV n per spleen (mean) 
a) 2 X 105 3 2.0 
b) 2 X 105 10 1.1 
a) 5 X 105 6 6. I 
b) 5 X 105 9 2.2 
a) 2x 105 +RLV 1.0 
b) 2 X 105 + RLV 5 2.2 
a) 5 X 105 + RLV 3 3,6 
b) 5x 105 +RLV 4 4,5 
CFU per 106 injected 
spleen cells 
10.0} 7.-f' 
5.5 
12.2} 
8.3 
4.4 
5.0} 8.0 
11.0 
7.2} 8.1 
9.0 
Results: In both experiments the number of spleen colonies 
counted in the mice which received virus differed only slightly from 
the number of colonies counted in the control group. In the first 
experiment (a) the difference was in favour of the controls (without 
RL V), in the second (b) in favour of the group which received virus. 
It was concluded that the method could be applied in Rauscher 
leukaemia to measure the colony forming units (CFU). 
In order to follow the changes in the number of colony forming 
units in the course of the induction and the establishment of 
Rauscher erythroblastosis, the number of CFU's present in the spleen 
was estimated at various intervals after the infection of BALB/ c mice 
with Rauscher Leukaemia Virus (RL V). 
Two procedures were followed. In the first, all donor animals 
were infected with RL V simultaneously and at various intervals 
thereafter spleen colony assays were performed of spleen cell suspen-
sions of small groups of infected mice. In the second procedure, the 
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donors were infected with RLV at various intervals before their 
sacrifice and the colony assays were performed simultaneously for all 
groups. The results of both experiments were similar. 
I. Female BALB/c mice, 4 weeks of age were infected with 
0.2 ml of the undiluted RLV preparation; a few hours later the first 
group of donors were sacrificed for splenic CFU estimation. Twice a 
week 3-6 mice were killed for the performance of a spleen colony 
assay as described in Chapter Ill. The experiment was repeated 
several times. Cell suspensions were made either of pooled spleens 
(A) or of single spleens (B). 
The colony counts obtained in these experiments are shown in 
Table V, experiment rA and JB. 
Table V. Number of colony forming units per 106 spleen cells of BALB/c mice infected 
with RLV, determined at various intervals after the infection. Between brackets 
the number of spleens in which the colonies were counted. 
Days after Rl V-
Experiment lA Experiment 18 inoculation Experiment II 
of donors (pooled spleens) (single spleens) (pooled spleens) 
0 75 100 - 31 29 -
(13) (/8) ( 8) ( 8) 
1 
- - - - -
93 
(15) 
3-4 60 29 47 39 27 99 
( 9) (15) (12) (17) ( 8) (18) 
7-8 66 - - - - -
(14) 
10-11 - 25 27 55 34 103 
( 8) (11) (17) (13) (15) 
14-15 86 - - - - 61 
(13) (15) 
17-18 - - 31 25 - -
(13) (29) 
21-22 15 - 39 22 - 109 
(12) ( 8) ( 4) (20) 
28-29 39 - - - - -
(20) 
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II. Groups of 5 BALBI c mice, 4-5 weeks of age, were infected 
with RLV, 21, 14, II, 4 and I days before sacrifice. The spleen 
colony assay was executed simultaneously for all groups of infected 
mice. 
The results of this experiment are given in Table V, experiment 
II. 
Results: Considerable differences existed between the CFU con-
tent of the individual spleen cell suspensions. Just as in experiment I, 
the high colony counts are striking. These could not be ascribed to 
admixture of virus-induced foci, as was shown above. It is question-
able whether the high values represent a real increase in CFU, since 
they were found already few hours after the injection of virus and 
during the whole course of the disease. As is shown in Fig.l4, where 
the results of all colony tests performed with leukaemic spleen cells 
are collected, no c6nsistent change in the mean number of CFU per 
I o6 spleen cells could be detected in the course of Rauscher erythro-
blastosis. Even in mice with an enormous splenomegaly and a high 
nucleated cell count of the peripheral blood, the number of CFU per 
I o6 spleen cells was comparable to that of recently infected mice. 
Since the absolute number of spleen cells increased concomitantly 
with the increase in spleen weight, i.e. 20- to 30-fold, an increment 
of CFU of the same extent can be calculated. 
CFU per 106 
spleen celts 
100 • 
• 
BO 
• 
• 
• 
60 • 
40 • 
~ • ~ 
• • • • • 20 
• 
• • 
0 
0 3-4 7-B 10-11 14-15 17-1B 21-22 28 
days after RLV -inoculation 
of donor mice 
Fig.l4. Colony forming units (CFU) per 106 spleen cells obtained from BALB/c mice at 
various intervals after infection with RLV. 
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Histology of spleen colonies 
A histological analysis was performed of spleen colonies produced 
in lethally irradiated mice by the injection of either normal or leu-
kaemic spleen cells. Leukaemic spleen cells were obtained from mice, 
which were infected at least three weeks previously with a high dose 
of RLV, i.e. 0.2-0.5 ml of the undiluted cellfree spleen extract. 
One hundred colonies of both series were examined and the cell 
types constituting the colonies were determined. The percentage of 
colonies which consisted either of erythro blasts, of myelocytes and 
myeloblasts, of megakaryocytes or of a combination of these cell 
types was calculated. 
Results: As can be seen from Table VI the colony forming cells of 
the leukaemic spleens could give rise to a variety of cell types. The 
Table VI. Spleen colonies in lethally irradiated mice, 10 days after the injec~· 
tion of normal (N) and leukaemic (L) spleen cells, arranged ac-
cording to the type of cells constituting the colony. Between 
brackets the number of colonies in each category apparently con-
sisting of only one cell type. 
Erythroid Myeloid Megakaryoti c Undetermined Total 
N. 66 (20) 68 (20) 22 (3) 9 (4) 100 
L. 71 (35) 51 ( ll) 24 (5) 9 (5) 100 
similarity in distribution of the types of colonies produced by leu-
kaemic and by normal spleen cells is striking. Among the colonies 
produced by leukaemic cells only a slightly greater percentage of 
erythroid colonies was found. It may be concluded that the stem 
cells in the leukaemic spleen retain their pluripotency, at least to a 
certain extent. 
Repopulating capacity of leukaemic spleen cell suspensions 
In Rauscher erythroblastosis splenic stem cells not only can form 
colonies of different histological types in the spleens of irradiated 
mice, but also are capable of repopulating the depleted haemato-
poietic organs in these mice and can build up a new blood forming 
system. This can be deduced from the observation that a sizeable 
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fraction of lethally irradiated mice survives for 30 days or more after 
the injection of spleen cells, obtained from the enlarged spleens of 
mice suffering from Rauscher erythroblastosis. Preliminary data even 
suggested that equal numbers of either leukaemic or normal spleen 
cells were required for the survival of 50% of the irradiated mice for 
at least 30 days (Brommer e.a. 1970). These experiments have been 
extended and the results could be reproduced. All data pertinent to 
the survival of lethally irradiated and restored mice were conformed 
to a pro bit curve, shown in Fig.l5. 
From these lines it can be inferred that the bone marrow syn-
drome can be overcome by the restitution of leukaemic cells almost 
as effectively as with normal spleen cells. Thus, the conclusion seems 
warranted that the stem cells in the leukaemic spleens not only main-
tain their relative numbers but also retain their pluripotency: they 
can give rise to a variety of colonies and the distribution of the 
%survival 
99 o normal spleen eel ls 
• leukaemic spleen cells 
90 
70 
50 
30 
10 
106 1Q1 
number of spleen cells injected 
Fig.l5. Probit curves of the survival of BALB/c mice 30 days after lethal irradiation and 
restoration with leukaemic spleen cells versus normal spleen cells; 95% confidence 
limits indicated by horizontal bars. 
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histological types is almost normal; they are capable of restoring 
lethally irradiated mice almost as effectively as normal stem cells, 
suggesting that they may produce normal functioning end cells. 
In order to investigate as to how far the stem cells escape the viral 
attack a method was selected to demonstrate the presence or absence 
of the virus from these cells. 
Effect of anti-RLV antiserum on CFU's 
Attempts were made to demonstrate the presence of viral anti-
gens upon the surface of the colony forming cells in the spleens of 
mice infected with Rauscher virus. For this purpose spleen cell sus-
pensions were incubated with rabbit anti-RLV antiserum before the 
injection into irradiated recipients; if less colonies would arise from 
these incubated cells than from buffer-incubated controls, this would 
indicate the eradication of a corresponding number of colony 
forming cells, presumably by the interaction of the antiserum with 
virus-specific antigens upon the stem cell membrane. Analogous ex-
periments have been performed in Friend disease by Steeves (1968), 
Thomson and Axelrad (1968) and Thomson (1969). 
I. Donors were female BALB/c mice, inoculated with 0.5 ml of 
undiluted RL V at the age of 8 weeks and sacrificed 17 days later. 
Cell suspensions were prepared from 4 enlarged spleens; 4 normal 
spleens were processed in the same way. The cell suspensions were 
diluted in Hanks BSS to contain 107 viable cells per ml; 15 ml of 
each suspension were incubated for 45 minutes at 37°C with an 
equal volume of rabbit antiserum or with control medium. After 
incubation the suspensions were centrifuged for I 0 minutes at 
1000 rpm. The supernatant was discarded and the pellets were re-
suspended in Hanks BSS so as to obtain cell concentrations of 
5 x I o5 and I o5 cells per 0.5 ml, calculated from the initial cell 
counts. Of each suspension 0.5 ml was injected intravenously into 20 
irradiated mice for a spleen colony assay. Ten days later the reci-
pients were sacrificed and the spleen colonies counted. 
Results: In a pilot study, unabsorbed rabbit sera were used. The 
rabbit anti-RLV antiserum appeared to be cytotoxic both for leukae-
mic and for normal mouse spleen cells (Table VII). In the control 
experiment with normal rabbit serum a toxic effect upon normal 
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spleen cells was noted. Remarkably, the majority of the leukaemic 
CFU's survived after the incubation with the same rabbit serum, 
suggesting that certain receptors were absent from the surface of the 
leukaemic cells. The experiment was repeated with rabbit sera ab-
sorbed with normal mouse spleen cells (Table VIII). 
In these experiments, again, the high values of the colony counts 
obtained with leukaemic spleen cell suspensions are noteworthy. 
Table VII. Cytotoxic effect of rabbit anti~RLV antiserum on the colony forming units 
of normal and leukaemic spleens, compared to the effect of the suspension 
medium and normal rabbit serum (non-absorbed sera! ). 
colony forming units/ 106 spleen cells 
Incubation medium 
normal spleen cells leukaemic spleen cells 
Hank's balanced salt solution 18 87 
normal rabbit serum 60 
rabbit anti-RLV 0 0 
Table VIII. Cytotoxic effect of rabbit anti-RLV antiserum on the colony forming 
cells of normal and leukaemic spleens, compared to the effect of suspension 
medium, non-absorbed and absorbed normal rabbit serum. Each figure re-
presents the mean colony count in 20 spleens 10 days after grafting of the 
incubated cells in lethally irradiated recipients. 
(abs NMSC =absorbed with normal mouse spleen cells). 
Incubation medium 
Hank's balanced salt solution 
normal rabbit serum 
normal rabbit serum - abs NMSC 
anti-RLV I 
anti-RLV I - abs NMSC 
anti-RLV II 
anti-RLV 11 - abs NMSC 
92 
6 CFU/ 10 spleen cells 
normal spleen cells leukaemic spleen cells 
28 130 
38 
10 
30 
9 
36 
40 
155 
2 
4 
18 
41 
Rabbit anti-RLV antiserum proved to be cytotoxic for leukaemic 
spleen cells and to eradicate the CFU's from the cell suspensions 
effectively. Normal spleen cells were also killed by the rabbit anti-
serum, but this effect appeared to be due to a factor present in 
normal rabbit serum. Since normal rabbit serum absorbed with nor-
mal mouse spleen cells did not kill leukaemic spleen cells, the eradi-
cation of leukaemic CFU's by the anti-RLV antiserum could be 
ascribed to the specific action of thls antiserum. In this way indirect 
evidence was obtained for the presence of viral antigens upon the 
surface of the leukaemic stem cells. Moreover, other antigens had 
apparently disappeared from the cell membrane of the leukaemic 
spleen cells. 
Conclusion: As for the susceptibility of the CFU to anti-RLV, 
Rauscher leukaemia is similar to Friend leukaemia, in whlch Steeves 
(1968) and Thomson (1969) demonstrated the abolition of the 
splenic "tumour colony forming cells" by anti-Friend virus anti-
serum. As stated before, these "tumour colony forming cells" pos-
sibly represent haematopoietic precursor cells. It is tempting to as-
sume that the antigenic changes are the result of the viral activity 
within the genome of the colony forming cells. Thls would imply 
that the virus had been present withln the colony forming cells or in 
their precursors during one or a few cell divisions before the assay. 
A remarkable finding was the cytotoxic effect of normal rabbit 
serum to normal mouse spleen cells. On the analogy of the cytotoxic 
action of rabbit serum to lymphoid cells of mice and rats (Palm 
1961, Boyse e.a. 1970, Colley e.a. 1970) thls might be an antibody 
effect. Presumably, the altered sensitivity of the leukaemic spleen 
cells to the naturally occurring cytotoxic factor in rabbit serum is the 
consequence of the appearance of viral antigens upon the cellular 
membrane. The possibility that it constitutes an independent change 
can, however, not be dismissed. Thls would be another argument for 
the transformation of the haematopoietic stem cell under the in-
fluence of Rauscher virus. 
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CHAPTER VI 
THE RESTORED MOUSE 
The bone marrow syndrome which develops after lethal irradia-
tion can readily be overcome by the injection of suspensions of 
normal isogeneic bone marrow or spleen cells. Mice restored in this 
way are apparently able to cope with the weal and woe of life and 
have a normal life span. The formation of a new haematopoietic 
system out of the injected pluripotent stem cells reconstitutes the 
ability to combat bacterial infections, to prevent bleeding and to 
maintain a normal haemoglobin level. 
If instead of cells from normal spleen or bone marrow, spleen 
cells are injected, derived from a donor mouse with a leukaemia-like 
disease - i.e. Rauscher erythroblastosis - not only leukaemic, non-
functioning tissue proliferates, as might be expected, but also normal 
blood elements are formed. These blood cells ensure the survival of 
the recipients for at least a month, whereas the non-injected controls 
die within two weeks. (Chapter V). 
In mice restored with leukaemic cells, however, viral infection is 
inevitable: washing the cells does not remove the virus because it is 
also localized within the cells and incubation with anti-RLV anti-
serum kills the stem cells and counteracts the repopulation of the 
haematopoietic organs. Thus, mice restored with leukaemic cells, 
develop erythroblastosis in due course. Nevertheless, these animals 
can live much longer than a month, as appears from the next ex-
periment. 
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Survival 
40 BALB/ c mice, I 0 weeks of age, irradiated with 700 rads whole 
body irradiation, received I o6, respectively 5x I o5 cells intravenous-
ly, obtained from the enlarged spleens of 7 weeks old donor mice, 
which had been infected with RLV 21 days previously. 
The recipients were kept for approximately three months and the 
surviving animals were recorded daily. The results are depicted in 
Fig.l6. After 3 months the leukaemic survivors were in a very bad 
condition and for that reason all animals were killed. 
700rads 
0 
%survival 
40 
20 
············· 5.106 normal spleen cells 
-- 1~ leukaemic spteen cells 
----- 5.10 leukaemic spteen cells 
+ ........................................................ ] 
: ................................................ . 
.. _1 
' 
' L----------------------------· 
60 80 100 
days 
Fig.l6. Survival of BALB/c mice after lethal irradiation and restoration with nor~ 
mal and leukaemic spleen cells. The experiment was terminated when 
the condition of the animals was critical. 
* mice killed and used for another experiment. 
As the curve of the percentage surviving mice shows, their chance 
to survive as long as 80 days is approximately 55%. Most animals 
died during the critical period between day 8 and 14, when also 
many mice treated with normal spleen cells die. Thereafter, they 
have a fair chance to survive 2 - 3 months. The cause of death will be 
studied below. 
The long survival - as compared to primary infected intact ani-
mals - could theoretically be due either to a slow progression of the 
erythroblastosis or to a longer time-lag before a perceptible prolifera-
tion of leukaemic cells commences. This was excluded by the follow-
ing experiments. 
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Spleen weight 
75 BALB/c mice, 10 weeks of age, irradiated with 700 rads 
whole body irradiation, were restored with either 106 or 5.106 
spleen cells from a leukaemic donor mouse, infected with RL V 21 
days before, or with I o6 normal spleen cells. The restored mice were 
kept in numbered cages in groups of 5. Twice a week one group was 
sacrificed in the order indicated by the numbers of the cages, and the 
spleens were weighed (Fig. I?). 
5.'06 ieukcemic spleen cells 
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Fig.17. Spleen weights of BALB/c mice restored after 700 rads whole body ir-
radiation (WBI) with 5 x 106 leukaemic spleen cells (curve), 105 normal 
spleen cells (n.s.c.), 105 leukaemic bone marrow cells (Lb.m.c.) or 106 
leukaemic spleen cells (l.s.c.). Leukaemic cells were obtained from syn-
geneic mice infected with RLV 17 to 21 days prior to this experiment. 
The spleen weight dropped to approximately one third of the 
initial value after the irradiation; whereas the spleen weight of mice 
restored with normal spleen cells returned to normal, the spleens of 
mice receiving leukaemic cells grew exponentially until a mean 
weight of ± 700 mg was attained at day 18. Thereafter the spleen 
weight remained constant for at least ten days, when the experiment 
was terminated. 
Although the starting point was somewhat lower than in intact 
animals, there was no time-lag in the growth of the spleen. Neither 
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was a slower progression of the spleen weight noted, the slope of the 
curve being even steeper than that of the spleen weight of infected, 
unirradiated mice. It is not clear why there is a maximum at a weight 
of less than one gram. The following possibilities were envisaged: I) 
the number of stem cells in the irradiated mouse is limiting; 2) there 
is a greater demand for differentiated cells, distracting a proportion 
of the stem cells. 
The first possibility was investigated by injecting different num-
bers of spleen and bone marrow cells. 
Bone marrow and spleen cell suspensions were prepared from the 
organs of BALB/ c mice, inoculated with 0.3 ml of the undiluted 
RLV extract, resp. 14 and 21 days previously. Graded numbers of 
viable cells were injected in lethally irradiated recipients: 10 weeks 
old BALB/c mice; the radiation dose was 725 rads. After 30 days the 
surviving animals were killed and their spleens weighed (Table IX) 
and Fig. 1 7). 
In these experiments no relation was found between the number 
of bone marrow or spleen cells injected and the spleen weight 30 
Table IX. Spleen weight of BALB/c mice 21 days after 700 rads whole body irradiation 
and grafting of various numbers of bone marrow and spleen cells obtained 14, 
respectively 21 days after the infection of syngeneic donor mice with RLV. 
Day after 
Number ond origin 
RLV-
Number of mice Spleen weight in inoculation mg 
of injected cells of donors in jected/survi vi ng {mean) 
5 1 0 bone morrow 14 12 I 4 880 
21 lO I 4 775 
3 • 105 .. 14 10 I 5 706 
21 10 I 2 725 
106 .. 14 10 I 6 860 
6 10 spleen cells 14 10 I 400 
21 lO I 5 1110 
3 • 106 .. 14 10 I 6 550 
21 10 I 0 
Jl .. 21 10 I 4 850 
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days later; the maximal spleen weight was already attained with the 
lowest number of cells administered in this experiment. Consequent-
ly, the number of stem cells injected seems not to be limiting for the 
splenic growth, at least within the range of cell numbers studied. 
The interval of time between the infection of the donor mice 
with virus and the use of their spleens for the preparation of the cell 
suspension had no influence upon the growth of the spleens in mice 
restored with the leukaemic spleen cell suspensions. 
Conclusion: Three weeks after the reconstitution, the haemato-
poietic apparatus seems to be completely restored. Consequently, the 
withdrawal of cells for differentiation into other directions than the 
erythroid cell line is not a likely cause of the cessation of the growth 
of the spleen. 
Presumably, the expanding leukaemic cell mass needs a constant 
influx of cells from a normal stem cell pool. As this stem cell pool is 
destroyed in irradiated mice and regains its original size only after a 
certain period of time, this might be a limiting factor in the increase 
of leukaemic cells in spleen and liver. 
Remarkably, the mice restored with leukaemic spleen cells sur-
vived much longer than non-irradiated mice infected with RLV. 
Presumably, this long survival is associated with the cessation of 
spleen growth. However, notwithstanding this seeming arrest in the 
leukaemic proliferation, the animals became progressively ill and died 
after two or three months in a very bad general condition. The 
factors responsible for this deterioration will be considered below. 
The presence of infective virus in the blood of the restored mice 
was investigated by the injection of plasma into weanling BALB/c 
mice. The rapid induction of erythroblastosis indicated that there 
was a high titer of virus in the plasma of the animals restored with 
leukaemic spleen cells. Another finding was that the injection of 
fresh virus preparations in to mice restored with leukaemic spleen 
cells did not accelerate the evolution of splenomegaly. Obviously, the 
virus titer in these animals does not constitute a limiting factor. 
Presumably all target cells in these animals have been in contact with 
the virus and other factors determine their fate. 
Histology 
The injected leukaemic stem cells home in the haematopoietic 
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organs and form colonies just like normal stem cells. 
In the spleen, the colonies which have a varying cellular constitu-
tion, coalesce after II to 14 days and populate the whole spleen, 
which soon exceeds its original size. Under the microscope an abun-
dance of haematopoietic cells can be discerned, differentiated in all 
directions. Lymphocytes seem to return in the perivascular shealths, 
erythroblasts are seen dispersed in the red pulpa and there are areas 
where myelocytes and mature granulocytes predominate. Megakaryo-
cytes also contribute to the repopulation of the spleen. The splenic 
capsule is often thickened by fibrosis. 
In the liver, foci of foreign cells can be found which are mostly 
constituted of poorly differentiated cells with a bloated, round nu-
cleus, probably primitive erythroid elements, and mature erythro-
blasts. In later stages, the liver parenchyma is heavily infiltrated with 
these cells as well as with myelocytes and some megakaryocytes. 
All haematopoietic cell lines are abundantly represented in the 
bone marrow. Though in some preparations mainly erythroid ele-
ments are detectable, there is no evidence for a crowding out of the 
granulopoiesis. On the contrary, myelocytes and mature granulocytes 
often dominate the picture, especially in later stages, when the cel-
lularity of the bone marrow is extremely high. 
Table X. Haematocrit, nucleated cell counts and platelet counts (means ±S.D.) in the peri~ 
pheral blood of BALB/c mice at various intervals after 700 rads whole body ir~ 
radiation and restoration with leukaemic spleen cells. n =number of mice. 
Day after Hoematocrit Nucleated cells Platelets 
grafting (%) (x 106/1) (x 106 /1) 
n n n 
7 5 46.5 ::': 2.8 5 1090 + 360 5 75,000 ::': 64,000 
-
14 4 25 + 9.0 4 670 + 360 3 15,000 ::': 4,300 
-
17 4 22 + 6.7 3 10,700 ::': 5100 2 27,000 ::': 6,400 
21 3 33 + 8.7 3 30,000 ::': 14,700 3 46,000 ::':· 30,200 
31 7 35.4 ::': 2.7 7 32,700 ::': 15,500 6 205,000 ::': 181,000 
38 4 40.4 ::': 5.1 4 13,400 ::': 3700 4 90,000 ::': 30,900 
49 3 35.6 ::': 9.1 2 41,400 ::': 30,600 4 53,000 ::': 12,500 
61-77 5 40.6 ::': 6.5 2 91,500 ::': 41,000 -
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Haematology 
From different experiments the data concerning the haematocrit, 
total nucleated cell counts and platelet counts were collected to get 
an impression of the functional status of the haematopoietic appara-
tus at various intervals after the restoration (Table X). As judged 
from these figures, after a drop in the haematocrit in the first two or 
three weeks, a slight increase seems to occur in the fourth week, 
indicating some differentiation of the stem cells into the erythroid 
direction, resulting in functional end cells. 
The leukocyte count recovers in the third week. Very high peri-
pheral leukocyte counts are encountered at day 21. The peripheral 
blood in these restored animals did not differ from that in primary 
infected, non-irradiated mice. 
The platelet count, too, showed a tendency to recover after leu-
kaemic spleen cell transplantation. In a single experiment values were 
found, which did not differ much from those seen in mice restored 
with normal spleen cells. In most experiments, rather low values were 
found throughout the observation period. 
Immunoglobulins 
In 4 mice restored 65 days previously with leukaemic spleen cells, 
immunoglobulin levels in the plasma were estimated semi-quantative-
ly by immunoelectrophoresis, agar gel-electrophoresis and the Wieme-
technique (Wieme 1959), kindly performed by Dr Radl, Institute for 
Experimental Gerontology, TNO, Rijswijk. 
All immunoglobulin levels appeared to be depressed substantially 
as compared to normal controls (Fig.l8) There were no M-compo-
nents present, as have been found in a human baby suffering from a 
severe immune deficiency syndrome during the recovery of lympho-
poiesis after thymus grafting and bone marrow transplantation (Radl 
e.a. 1972). 
Liver function 
The massive infiltration of the liver by the haematopoietic cells 
understandibly leads to some impairment of liver function. It was 
attempted to substantiate this by chemical analysis of the blood. A 
reliable technique for the measurement of ammonia levels in the 
mouse was not available. An estimation of the ammonia level in the 
plasma of two mice restored 65 days previously, kindly performed 
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Experimental 
animal nr. 
2 
3 
4 
Normal control 
Fig.18. Immunoelectrophoresis of plasma of BALB/c mice 65 days after lethal irradiation 
and restoration with leukaemic spleen cells, showing an appreciable reduction of the 
immunoglobulin levels. Antiserum: rabbit anti-mouse immunoglobulins (nr 156). 
by Mr Blijenberg, Academic Hospital Dijkzigt, Rotterdam, revealed 
high values, roughly twice normal (controls: normal uninfected 
BALB/c mice, same age). 
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Table XL SGOT-estimations in 5 restored mice, 61, 68 and 75 days 
after 700 rads whole body irradiation and grafting of 
5 x 106 leukaemic spleen cells, compared with normal 
BALB/c mice and RLV-infected controls, 21 days after in-
fection. 
Mouse nr. 61 days 68 days 75 days 
112 - 5 520 t -
112 - 8 234 214 240 
112 - lO - 251 260 
112 - 18 244 191 240 
112 - 21 298 t -
Normal 30,5 + 6.6* 
controls 
RLV-infected ~ 68 
controls 
Table XII. SGPT-estimations in 5 restored BALB/c mice, 61, 68 and 
7 5 days after 700 rads whole body irradiation and grafting 
of 5 x 106 leukaemic spleen cells, compared with normal 
BALB/c mice and leukaemic controls, 21 days after virus 
injection. 
Mouse nr, 61 days 68 days 
112 - 5 34 t 
112 - 8 24.8 77 
112 - 10 - 103 
112 - 18 39,6 61 
112 - 21 132 t 
Normal 17,4 :!: 7,6* 
controls 
RLV-infected 14,1 + 
controls -
t died spontaneously 
mean of 8 mice 
1.1 ** 
** mean + S.D. of 5 mice 
75 days 
-
103 
26 
26 
-
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Transaminase levels were estimated by Mr van Bezooyen, Insti-
tute for Experimental Gerontology, TNO, Rijswijk. SGOT-levels 
were extremely elevated as compared with simultaneously estimated 
controls (Tabel XI). This could in part be due to haemolysis. The 
SGPT-levels (Tabel XII) were also substantially elevated, suggesting 
necrosis of liver cells. However, these values were nor so high as to 
explain the death of the animals. 
Cause of death 
The death of the mice restored after lethal irradiation with leu-
kaemic spleen cells could not be attributed to progressive leukaemic 
infiltration in the haematopoietic tissues or the liver. In order to 
determine the cause of death 4 restored mice were observed atten-
tively and either sacrificed moribund and autopsied or examined 
soon after spontaneous death. 
Remarkably, lymph nodes could not be found in these animals. 
After the irradiation and transplantation of leukaemic spleen cells 
the thymus apparently did not recuperate either. The only lymphatic 
tissue which could be detected consisted of a few questionable 
lymphocyte foci in the spleen. 
In the small intestine lymphatic follicles were absent. The intesti-
nal epithelium was intact. In several animals infestation by worms 
was noticed, which is a common finding in healthy animals, too, but 
reactive changes were conspiciously absent, in accordance with an 
immune deficiency. 
The kidneys were normal. 
The most dramatic changes were found in the lungs. In each of 
the 4 mice one lung appeared solid and oedematous on macroscopic 
inspection; sometimes also part of the other lung was affected. 
Microscopically, the alveoli appeared to contain fibrin, the alveolar 
walls were thickened by hyaline material, characteristic for hyaline 
membrane pneumonia. The alveolar septa were oedematous and dis-
played an increased cellularity; many giant cells were seen, some of 
which contained large, bright red nuclear inclusion bodies, suggesting 
a viral genesis of the pneumonia. A few erythroblasts were encoun-
tered in the affected alveolar septs. There was, however, no evidence 
for substantial leukaemic infiltration in the lungs (Fig.l9). These 
changes provide a satisfactory explanation for the death of the mice. 
Presumably, an immunological deficiency is the major factor 
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leading to an increased susceptibility to infections, terminating in a 
fatal pneumonia. 
Fig.19. High power view of lung section of BALB/c mouse 65 days after lethal irradiation 
(700 rads) and restoration with leukaemic spleen cells: hyaline deposits in alveolar 
walls and increase in cellularity of alveolar septs; fibrinoid material in lumen (HPS 
X 360). 
Conclusion 
In summary, the injected leukaemic spleen cells appeared to be 
able to repopulate the complete haematopoietic system. Not only 
granulopoiesis and thrombopoiesis occurred, but functioning ery-
throcytes were also produced by the reconstituted haematopoietic 
organs. The mice did not become severely anaemic and sometimes 
even a rise in haematocrit was seen. 
The aspects of the blood forming organs in the restored mice 
resembled that of primarily infected, non-irradiated mice of the same 
strain. In bone marrow and spleen erythropoiesis dominated, but 
other cell types could be traced, too. 
The spleen weight increased even faster than in virus-infected 
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mice, but, curiously, after three weeks it attained a plateau. The 
number of stem cells injected seemed not to be a limiting factor for 
the ultimate spleen weight. The fibrosis of the splenic capsule and 
the absence of massive haemorrhages in the organ obviously played a 
role. However, the long survival time indicates that the leukaemic 
proliferation is slower in the restored than in a normal mouse. The 
explanation of this phenomenon might be sought in a decreased 
influx of newly recruited cells from intact bone marrow into the 
leukaemic population. 
Notwithstanding the arrest in spleen growth and the absence of 
leukaemic proliferation, the animals died after 1-3 months, in con-
trast to the control mice restored with normal spleen cells. Death 
could be attributed to pneumonia, presumably of viral origin. Since 
the Rauscher virus itself has no effect upon the lungs, a superinfec-
tion due to the immunological deficiency of the animals restored 
with leukaemic tissue must be assumed. 
The lethally irradiated mouse, restored with leukaemic spleen 
cells can be compared with a patient in complete remission after 
chemotherapy of blastic leukaemia: in both situations the haemato-
poietic organs are repopulated by cells, derived from stem cells pre-
sent among a leukaemic cell population. In this respect, it might be a 
suitable model of complete remission in human leukaemia. 
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CHAPTER VII 
DISCUSSION 
The main objectives for the study of an animal model for human 
leukaemia are in general: I) to gain insight in the pathogenesis of the 
disease, and 2) to test cytotoxic agents and therapeutic regimens. 
The transplantable leukaemias, especially L 1210, have proved to be 
excellent models for the evaluation of the efficacy of anti-tumour 
agents and have contributed to the introduction of effective schemes 
for the treatment of clinical leukaemia (Skipper 1968). These leukae-
mias, however, display some essential differences from human leu-
kaemia with respect to growth fraction (Gavosto 1970) and the auto-
nomy of the leukaemic cells. If virus-induced murine leukaemias 
were similar in this respect to human leukaemia these might consti-
tute a more suitable model for the study of leukaemogenesis. 
Since the initiation of this study the likelihood of a possible viral 
genesis of human leukaemia has increased, as judged from the many 
reports in the litterature dealing with this subject. Recent studies by 
Spiegelman c.s. (Hehlmann e.a. 1972) even suggest that a nucleic 
acid sequence similar to Rauscher virus might have causal significance 
both in murine and in human leukaemia. If this proves to be true, the 
study of Rauscher disease in particular might have more implications 
than supposed until recently. 
The natural history of Rauscher disease in BALB/ c mice, as ob-
served in this laboratory, corresponds with the splenic and hepatic 
erythroblastosis or erythroblastic leukaemia, described by other 
authors, whether induced by Friend or by Rauscher virus. The 
disease was restricted to the haematopoietic organs, especially spleen 
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and liver, the changes in the bone marrow being difficult to interpret. 
Infiltrations of leukaemic cells in other organs, as described by 
Yokoro e.a. (1966), were not encountered. 
In BALB/c mice there was no evidence for leukaemic prolifera-
tion of cell types other than erythroid elements. The granulopoiesis 
remained active throughout the course of the disease, without indica-
tions of a maturation arrest, accumulation of young cells or metas-
tases of myeloid cells. In some neonatally infected C57BL mice, 
however, granulocytic leukaemia developed with chloroma-like cell 
masses in mesenteric lymph nodes similar to the laesions described 
by Boiron e.a. ( 1965). This demonstrates the leukaemogenic poten-
tial of the Rauscher virus preparations used, with respect to the 
granulocytic cell line. The absence of such lesions in BALB/ c mice 
infected with the same virus, suggests that the stimulated granulo-
poiesis which was seen in the early phase of erythroblastosis, is not 
the expression of myelocytic leukaemia but rather an aspecific reac-
tion to the viral infection. 
Although the virus has been demonstrated by others within mega-
karyocytes and blood platelets, this is not tantamount to malignant 
transformation of these cells. In the present study the number of 
megakaryocytes was not abnormally high neither in the bone marrow 
nor in the spleen of the majority of the infected BALB/ c mice, as 
judged from the histological sections and the imprint preparations. 
Exceptionally, however, rather large numbers of megakaryocytes 
were encountered in the leukaemic spleens. The possibility of neo-
plastic proliferation of megakaryocytes, supposed by Brodsky e.a. 
(1968), cannot be excluded but does not seem likely. 
In his original article Rauscher (1962) described the development 
of lymphomas in rats infected with the newly discovered virus. 
Several other investigators have gained the same experience. The 
virus preparations used in this study, too, could induce lymphoma in 
rats. In BALB/c mice, however, lymphomas and thymic enlargement 
were never observed, which in all likelihood excludes a proliferative 
process of lymphatic origin. The often observed lymphocytosis in the 
peripheral blood of these mice must be attributed to aspecific stimu-
lation or mobilization, rather than to neoplastic proliferation of 
lymphocytes. 
The splenic disease in BALB/ c mice thus appears to be restricted 
to the pathological increase of erythroblasts and their precursors. 
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The supposition of Brodsky e.a. ( 1969) that the erythroblastosis is a 
compensatory mechanism brought into action to cope with the 
shortened erythrocyte survival time, does not account for the mag-
nitude of the splenomegaly and the liver involvement, even in face of 
a severe anaemia, let alone in case of a slight or moderate anaemia. A 
direct action of the virus on the kinetics of the erythroblasts must be 
assumed. The leukaemic cell mass largely consists of immature cells. 
Consequently, it might be inferred that the virus one way or other 
hampers the normal maturation of the infected haematopoietic cells. 
Only a minority of the red cells proceeds to a functional end stage, 
although they are often appreciably altered morphologically. The 
longevity of the immature cells contributes to the accumulation of 
leukaemic cells in spleen and liver. In these respects erythroblastosis 
resembles human leukaemia and combined with the fact that the 
process pursues its course relentlessly until the death of the affected 
animal, the erythroblastosis may be regarded as a malignancy. 
If it may be assumed that the spleen colony assay in tbis viral 
leukaemia can be interpreted in the same way as in the normal 
system, the present data indicate that in Rauscher leukaemia normal 
stem cells are present in the spleen. In the course of the disease their 
number increases I 0 to 30 fold. 
Theoretically, the colonies arising from the transplanted leukae-
mic spleen cells might be foci of tumour cells, as Thomson (1969) 
concluded, when she induced colony formation in irradiated mice by 
the injection of spleen cells obtained from mice infected with Friend 
virus. However, analysis of the colonies in the present experiments 
revealed an almost normal differentiative capacity of the splenic 
CFU's of leukaemic mice. It is therefore justified to call the cells 
wbich give rise to these colonies: 'colony forming units'; they may 
serve as a parameter for the pluripotent stem cell pool, instead of 
being merely 'tumour colony forming units' (Thomson 1969, Steeves 
1968). 
The normal functional capacity of the colony forming cells from 
leukaemic spleens is substantiated by the long survival of mice which 
receive 6 x 105 or more spleen cells after lethal irradiation. The exis-
tence of a dual population of stem cells, normal next to leukaemic, is 
bighly unlikely in view of the small difference in repopulating capa-
city of normal and leukaemic spleen cells. 
The normal functional capacity of the stem cells of mice infected 
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with an erythroblastosis virus has recently been confirmed: Wendling 
e.a. (1972) infected mice with the polycythaemia-inducing strain of 
Friend virus and observed a six-fold increase of the number of splenic 
colony forming units which followed the rise in the number of spleen 
cells. The distribution of the various types of colonies, 25-30 days 
after infection, did not differ much from normal. 
These experiments give no clue as to the origin of the colony 
forming cells. They might be generated in the spleen by the multipli-
cation of the stem cells present at the time of infection. Stem cells 
are known to increase in number under the influence of various 
stimuli, among others immunological challenge (Boggs e.a. 1967, 
McNeill 1970), hypoxia (Okunewick e. a. 1969) and bleeding (Marsh 
e.a. 1969). Multiplication of stem cells induced by the virus seems 
less probable but cannot be excluded. Though in individual spleens 
the number of CFU's per 106 cells sometimes greatly surpassed the 
values found in normal controls, the mean values did not differ from 
normal and did not change during the development of the leukaemia. 
The fact that the number of CFU's keeps pace with the total number 
of spleen cells suggests a physiological mechanism. 
Rencricca e.a. ( 1970) provided evidence for the migration of stem 
cells from the bone marrow to the spleen in mice with an increased 
demand for erythroid precursor cells, provoked by phenylhydrazin 
induced haemolytic anaemia. The increase in the numbersofCFU'sin 
the spleen coincided with a decrease of those in the tibia, as had been 
found previously by Marsh e.a. ( 1968). Furthermore, the CFU's in the 
bone marrow entered in active cell cycle whereas those in the spleen 
were resting. Hodgson e.a. ( 1968) reported an increase in CFU content 
of the peripheral blood in rats with phenylhydrazin-induced haemoly-
tic anaemia. Both data might indicate an increased release of stem cells 
from the bone marrow in response to anaemia. A similar compensatory 
mechanism might play a role in the splenomegaly or erythroblastosis. 
Stephenson e.a. ( 1972) found as much as 165 "tumour colony forming 
units" per I o6 cells in the peripheral blood of those mice in which an 
elevated nucleated cell count of more than 100 x 109/1 developed after 
infection with Friend virus. Although the factors responsible for the 
release of stem cells into the peripheral blood are not known, neither in 
leukaemic, nor in normal mice, the data are in keeping with the 
possibility that this mechanism contributes to the increase in CFU's in 
the enlarged spleen in erythroblastosis. 
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In addition to the action of the causative agent, the virus, an 
erythropoietic stimulus appears to influence the development of ery-
throblastosis, since hypoxia or exogenous erythropoietin promotes 
and polycythaemia induced by repeated blood transfusions delays 
splenomegaly (Tambourin e.a. 1969). At first sight this seems irre-
conciliable to the classical conception of the autonomous behaviour 
of malignant cells. However, even continuous hypertransfusion could 
not arrest the gradual progression of splenomegaly or prevent the 
premature death of mice infected with Rauscher or Friend virus 
(Dunn e.a. 1966, Tambourin I.e.). Besides, the cellular proliferation 
of several other tumours, both animal and human, can be influenced 
by hormone action, e.g. mammary carcinoma and prostatic carci-
noma, the malignant nature of these tumours being beyond doubt. 
The erythroid hyperplasia in Di Guglielmo's syndrome has been 
shown to decrease concomitantly with the erythropoietin excretion 
after hypertransfusion and thus appears to be influenced by physio-
logical factors (Adamson and Finch 1970). Furthermore, Metcalf 
( 1971) provided evidence for the responsiveness of human leukaemic 
blast cells to regulation, mediated by humoral substances. Recent 
observations on the oscillating course of some cases of chronic 
myeloid leukaemia (Shadduck e.a. 1972) are in favour of the respon-
siveness of this type of leukaemia to feed back regulation. Thus, the 
umesponsiveness of cancer and leukaemia cells to physiological regu-
lator mechanisms is not an absolute criterium. Apart from this, the 
most effective point of impact upon a cell renewal system, like hae-
matopoiesis, is not the end cell but the stem celL In the case of 
murine erythroblastosis it is conceivable that the hormone erythro-
poietin induces the differentiation of a primitive precursor cell into 
the erythroid direction and thus feeds the neoplastic population. The 
stem cells remain resting until a differentiating stimulus makes them 
enter into the expanding leukaemic cell population. 
Indeed, a constant influx of cells from a precursor pool into the 
erythroblastic compartment is essential for the spread of Rauscher 
leukaemia in the infected mouse. This could be deduced from the 
lack of autonomy of the majority of the proliferating spleen cells. 
After transplantation of leukaemic spleen cells into sublethally irra-
diated recipients, the greater part of the dividing cells in the enlarged 
spleens of the recipients were host-derived, indicating that new cells 
had been recruited from the host. Partial shielding of the bone mar-
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row greatly influenced the ultimate spleen weight in irradiated mice 
infected with RLV; obviously, the splenic disease is dependent on 
the immigration of cells from the bone marrow in these circumstan-
ces. In unirradiated mice these cells might arrive at the spleen from 
the same source. 
Many attempts have been made to determine the target cells for 
Rauscher and Friend virus. Although the presence of viral antigens 
on the colony forming cells has been demonstrated in Friend disease 
(Steeves 1968, Thomson e.a. 1968, Thomson 1969), this has not led 
to the conclusion that the colony forming cells might be the origin of 
erythroblastosis. The effect of hypoxia and polycythaemia on the 
evolution of erythroblastosis has been adduced in favour of the 
hypothesis that the erythropoietin responsive cell (ERC) be the 
target for Rauscher and Friend virus. However, these findings are 
compatible also with the induction of erythroblastosis via the infec-
tion of a more primitive precursor. Likewise, many attempts to 
promote or to counteract the evolution of Rauscher disease by in-
fluencing the stem cell pool (Brommer and Bentvelzen 1971 b) fail to 
differentiate between the ERC and the colony forming cells as the 
target for the virus. 
The virus seems not to be over-particular in the choice of its host 
cells. On the contrary, it is capable of infecting many types of cells. 
Virus particles have been found in megakaryocytes (Rauscher 1962), 
in reticulocytes (Zajdela e.a. 1968) and in other tissues without ma-
lignant transformation. The production of virus particles and trans-
formation of cells by RNA-virus are separate processes. Murine leu-
kaemia virus can replicate in various tissues but presumably only 
transforms haematopoietic cells; e.g. mouse mammary tumour virus 
multiplicates in haematopoietic cells without giving rise to·neoplasms 
of blood forming organs, stressing the importance of the epigenetic 
status of the host cell (Bentvelzen e.a. 1970). In the oncogene theory 
of Huebner and Todaro a distinction is made between the "viro-
gene", instructing for the production of viral proteins, and the "on-
cogene", the transformation-inducing gene. 
In the present study evidence was provided for the infection of 
the pluripotent, colony forming cells in Rauscher disease. These cells 
produce viral proteins, detectable as antigens on the surface of the 
colony forming cells. Nevertheless, the fate of these cells is not sub-
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stantially changed. The results obtained by restoration of lethally 
irradiated mice with spleen cells derived from virus-infected syn-
geneic animals indicate that the virus-bearing stem cells can give rise 
to normal haematopoietic cells. As judged from the thymic aplasia 
and the low immunoglobulin levels in the restored mouse, only the 
lymphoid cells seem not to recover adequately and the immunologi-
cal deficiency constitutes a life-threatening defect in these animals 
which, as a consequence, eventually die with pulmonary infections. 
If the leukaemia virus is incorporated in the DNA-chain of the 
pluripotent stem cells, it may be assumed that the genome of all 
progeny cells is endowed with the viral genes. However, in BALB/ c 
mice, the virus only induces appreciable changes in erythroid cells, 
resulting in malignant erythroblastosis, whereas granulopoiesis and 
thrombopoiesis proceed almost normally (Fig.20). Thus the develop-
ment of malignancy seems to depend on the direction of differentia-
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Fig.20. Differentiation-dependent transformation hypothesis of leukaemogenesis. 
The progeny of precursor cells committed and stimulated to differentiate 
in one direction reveals leukaemic features; other cell lines develop nor-
mally although all cells carry the genetic material capable of instructing 
for leukaemic transformation. 
(Differences in committed cells indicated by external symbols). 
tion of the target cells. In different mouse strains or in rats other cell 
lines are more vulnerable. 
To account for the almost normal development of virus-infected 
haematopoietic stem cells into granulocytes and megakaryocytes and 
the malignant derailment of erythroblasts, the hypothesis is pre-
sented that the transforming principle of Rauscher leukaemia virus, 
when penetrated into the cells of BALB/ c mice, is associated with a 
site of the host DNA-chain which instructs for erythroid differentia-
tion. 
This association might be effectuated in several ways. First of all, 
the oncogenic component of the virus might be incorporated in a 
part of the host DNA-chain involved in erythroid differentiation. On 
the analogy of the specific "puff patterns" in the giant chromosomes 
of Chironomus (Beermann 1952) and Drosophila (Berendes 1965), it 
is probable that for each differentiated cell type in higher organisms 
one or more specific sites of the DNA-chain are unfolded and acti-
vated by a specific stimulus to arrive at the specialized function of 
the cell. This mechanism obviously is not restricted to ontogenesis; it 
must be functioning also in the adult animal since in many tissues 
continuous replacement of cells takes place until death, e.g. in the 
skin, in intestinal and other epithelia and in the bone marrow. Undif-
ferentiated stem cells are preserved in these organs during the whole 
life span. They are capable of responding to adequate stimuli with 
differentiation, proliferation and maturation. If it is assumed that a 
potentially carcinogenic alteration, e.g. a (pro )virus, is inserted into 
the DNA-chain during a preceding nuclear division, it is conceivable 
that malignancy, induced by this fault in the genome will be mani-
fested only when the DNA-sequence concerned is prepared for 
transcription. In a primitive, undifferentiated cell this latent malignan-
cy will not be expressed. Only the evolution of a particular specia-
lized cell function will reveal the presence of the carcinogenic factor. 
The same hypothesis can be applied to the vertically transmitted, 
"germinal" provirus or oncogene. 
Secondly, the interference of gene products of the infecting virus 
with the production or function of cellular regulator substances 
might result in a hormone dependent transformation. Only in those 
cells in which the maturation depends on the function of these spe-
cific regulator substances the machinery of the cell will be disturbed 
and in appropriate circumstances malignancy may become manifest. 
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Presumably, erythropoietin acts by derepression of that segment 
of the genome which codes for the initial step in erythroid differen-
tiation (Hodgson 1970). In the case of Rauscher erythroblastosis, 
erythropoietin would also initiate the transcription of the oncogene 
in differentiating precursor cells or unmask it otherwise, triggering 
the malignant derailment of erythropoiesis. 
As this hypothesis has also to account for the development of 
other types of haematopoietic neoplasms in other animals, induced 
by the same virus, it must be assumed that the genetic constitution 
of the host determines the site or sites of the DNA chain were the 
(pro)virus is inserted or with which it interferes indirectly. In C57BL 
mice this would be a segment coding for granulopoietic differentia-
tion. The knowledge of the localization of genes upon chromosomes 
is only in its initial phase and more refined methods than hitherto 
available are required to enable the detection of the site of incorpora-
tion of a viral gene in the DNA-chain of infected cells and segments 
with specialized functions. 
According to this hypothesis it should be impossible or at least 
very difficult to induce transformation in the absence of the appro-
priate differentiating stimulus. Perhaps, the discrepancy between the 
ample evidence for radiation carcinogenesis in vivo in clinical and 
experimental medicine, and the difficulty to induce transformation 
by radiation under certain conditions in vitro (Klein 1966), should 
be regarded in this light. 
In lethally irradiated recipients the infected transplanted stem 
cells differentiate normally and are capable of reconstituting the 
complete haematopoietic system, except for the lymphatic organs. In 
the restored mouse erythropoiesis proceeds at a sufficient rate to 
maintain the haematocrit at a slightly depressed level. From this it 
may be inferred that under certain conditions the leukaemic erythro-
blasts can reach maturity, notwithstanding the hypothetical presence 
of an oncogene in the segment of the genome, instructing for this 
direction of differentiation. This may be compared with the observa· 
tion of Friend e.a. (1971), who induced haemoglobin production in 
cells obtained from a cultured cell line of murine leukaemia cells 
(Friend leukaemia) by the addition of dimethyl sulfoxide (DMSO). 
Reversion of malignancy has been reported in experimental 
pathology (Seilern-Aspang e.a. 1962, MacPherson 1965, Marin e.a. 
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1969, etc.) and in clinical pathology (see Pierce e.a. 1971), as well as 
in plant tumours (Braun 1965). Since single cells isolated from a 
malignant tumour - a mouse teratoma - were capable of giving rise 
to several types of differentiated cells, it is not necessary to have 
recourse to clonal selection to explain the regression of malignancy. 
Maturation can sometimes be induced in undifferentiated tumours 
by autotransplantation, suggesting the need of essential nutrients or 
other factors, or by growing them in vitro (Flaxman 1972). Induc-
tion of maturation of leukaemic blasts has been achieved in cultures 
of leukaemic cells obtained from the bone marrow or the peripheral 
blood of patients with leukaemia (Nowell 1960, Farnes e.a. 1961, 
Robinson 1970, Paran e.a. 1970, Ichikawa e.a. 1970, Metcalf e.a. 
1971, etc.). In some instances differentiation of malignant cells has 
been attributed to starvation (Rusch e.a. 1970) or to removal of 
nutrients from the culture (Seeds e. a. 1970). Of course, all examples 
of reversion of malignancy are not necessarily based on the same 
mechanism. The most likely factors in the restored mouse seem to be 
the combination of a strong stimulus for proliferation and differen-
tiation emanating from the environment and the absence of inhibi-
tory factors. This might eventually conduce to an epigenetic event 
which might be the final common pathway of multiple mechanisms 
leading to the same effect: differentiation and maturation of previ-
ously blocked immature cells. 
If neoplastic transformation is due to the action of an oncogene, 
transmitted within the genome of the cells, it must be assumed that 
this oncogene has been inactivated again in the cells reversed to 
normal. From the observations of the giant chromosomes it is known 
that the "puff patterns" change in the course of differentiation 
(Berendes 1967). Previously active puffs regress in subsequent dif-
ferentiation stages. Likewise, the genes necessary for the initiation of 
a specialized cell function - e.g. erythropoiesis - will be inactivated 
in more mature stages. If the proposed hypothesis is correct, the 
oncogene linked to these host genes either structurally or functional-
ly, will be suppressed conjointly, just like an acquired oncogenic 
provirus which does not cause malignant transformation in every cell. 
Interestingly, reversion of transformation of hamster cells, trans-
formed by a virus, has been shown to occur without loss of the viral 
genome (Rabinowitz e.a. 1969, 1970) and could be attributed to a 
suppressor, regulated by loci upon an identifyable group of chromo-
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somes (Hitotsumachi e.a. 1971). However, it is difficult to accept 
that mammalian cells possess regulatory genes commissioned to sup-
press acquired viral genes. Probably, the traced loci contain regulator 
genes which repress DNA-segments with which the oncogenes are 
associated. 
In conclusion, erythroblastosis induced by Rauscher or Friend 
virus may be conceived as the ultimate result of the disturbance of 
cellular processes elicited by the transcription of a provirus incorpo-
rated in the DNA-chain of the host. The viral genes are in one way or 
the other associated with erythroid differentiation. Consequently, 
only the maturation of erythroblasts is defective. Erythropoietin trig-
gers responsive cells (ERC) to differentiate and to participate in the 
leukaemic process. In turn, the pluripotent stem cell compartment 
receives a stimulus to compensate for the loss of ERC's (Lamerton 
1970). Since the majority of the red cells do not reach maturity, the 
feed back stimulation 
(erythropoietin) 
Erythropoiesis 
Other cell lines 
Fig.21. Hypothesis on the leukaemogenesis of Rauscher disease. Exogenous and 
endogenous erythropoietin enhance leukaemic proliferation. The lack of 
functioning red cells, maintained by the impaired maturation, provides a 
positive feed back to the stem cell compartment, stimulating the differen-
tiation into erythroblasts. By the competing demand on the stem cell 
pool the differentiation of other cell lines may be hampered. 
stimulus to the precursor pools does not cease. The continuous 
delivery of erythroblasts results in the accumulation of immature 
cells in spleen and liver (Fig.21 ). 
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Although the most conspicious abnormality in this disease is the 
increased cell mass in spleen and liver, largely consisting of immature 
red cells, the viral infection is not restricted to the red cell series. The 
most primitive haematopoietic cells, detectable by their function of 
pluripotent precursors are affected by the virus. These virus-bearing 
stem cells only wait for a physiological, differentiating stimulus to 
enter into the leukaemic process. Remarkably, if they are induced to 
differentiate to granulocytes or megakaryocytes their development 
will be virtually normal. Only the erythroid cell line derails and 
manifests malignant changes. Presumably, the expression of the 
malignancy ultimately depends on the physiological stimulation of 
that segment of the genome in which the provirus is incorporated. 
If the conclusions from this experimental model might be trans-
ferred to human leukaemia this would afford some interesting per-
spectives. The model demonstrates that a disease which is induced by 
viral infection has much in common with some types of human 
leukaemia. 
In the experimental model the leukaemic cells do not display 
autonomous proliferation. They are not self-maintaining and for the 
progression of the disease a constant influx is needed of cells, re-
cruited from the pluripotent stem cell pool. This would favour the 
view of Gavosto (1970) on human acute leukaemia and corresponds 
to the external influence theory. However, in erythroblastosis the 
recruited cells are infected already in an early stage, prior to the 
challenge to enter into the differentiating compartment. Presumably, 
the oncogene is incorporated in the genome of the stem cells and will 
be transmitted to daug)Jter cells. This suggests that the persistence of 
a leukaemogenic agent is not obligatory for the progression of the 
leukaemia. If, indeed, the pluripotent haematopoietic stem cells are 
infected in human leukaemia as has been demonstrated in Rauscher 
leukaemia, this might constitute a serious obstacle for therapeutic 
success. It would be impossible to eradicate all infected cells without 
killing the patient. The achievement of complete remissions in acute 
leukaemia does not refute this because relapse ensues in the majority 
of the cases. The lethally irradiated mouse restored with leukaemic 
cells seems to be a realistic model for complete remission of human 
leukaemia. Here, too, haematopoiesis is run by differentiated leukae-
mic cells. 
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It is to be hoped that human stem cells are not so readily at-
tacked by leukaemogenic agents as murine haematopoietic stem cells 
by the Rauscher virus. For the treatment of human blastic leukaemia 
this might have the implication that bone marrow transplantation 
after the complete eradication of the pre-existing stem cells and after 
anti-viral therapy would be the only way to get rid of the leukaemo-
genic germs. All regimens permitting the proliferation of autologous 
stem cells will allow the re-introduction of cells endowed with the 
(acquired) provirus and will fail to cure the disease, unless devices 
will be developed tore-initiate the maturation of the leukaemic blast 
cells in the patient. If human leukaemia will prove to be hormone-
dependent like murine erythroblastosis, this might open new perspec-
tives for the treatment of leukaemic patients. 
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SUMMARY 
Rauscher leukaemia virus (RL V) induces erythroblastic prolifera-
tion in BALB/ c mice if a sufficiently large dose of the virus is in-
jected. The incubation period of the disease is dose-dependent, in-
dicating that the number of target cells attained by the virus deter-
mines the course of the erythroblastosis, just as in non-oncogenic 
viral infections. 
Lethally irradiated BALB/c mice with partially shielded bone 
marrow acquire the same disease upon infection with RLV. The virus 
obviously may fmd its target in bone marrow cells. Presumably these 
cells migrate to the spleen and the liver where they divide and ac-
cumulate. In splenectomized mice, infected with RLV, the most im-
pressive changes are found in the liver; metastatic deposits were not 
encountered. These animals survived longer than the non-splenec-
tomized controls. In C57BL/Rij mice, infected neonatally, the same 
virus induces either lymphatic or myeloid leukaemia. 
Transplantation of leukaemic cells from Fl(BALB/c x CBA/ 
T6T6) into F1(BALB/c x CBA/Rij) and vice versa revealed the lack 
of autonomy of transferred leukaemic spleen cells. In the recipients 
the disease was propagated by the spread of the virus; the prolifera-
ting spleen cells could be identified by chromosomal analysis and the 
large majority appeared to be host cells. 
The relative number of stem cells in the suspensions of the 
spleens of BALB/c mice with erythroblastosis, measured by the 
spleen colony assay, remained approximately constant during the 
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development of splenomegaly. The absolute number of splenic stem 
cells thus increased proportionally to the total number of spleen 
cells, i.e. 20- to 30-fold. Arguments for the migration of newly re-
cruited stem cells from the bone marrow to the spleen are discussed. 
The stem cells from the leukaemic spleens had a normal dif-
ferentiative capacity, as judged from the distribution of histological 
types of the colonies which arose in lethally irradiated recipients 
upon injection of leukaemic spleen cells. Furthermore, the leukaemic 
spleen cell suspensions displayed an almost normal repopulating 
capacity in lethally irradiated recipients. Leukaemic spieen cell sus-
pensions could prolong the survival of these animals for several 
months. 
In contrast to the normal behaviour of the stem cells in the 
leukaemic mice, there is overwhelming evidence that they are af-
fected by the virus. The majority of the leukaemic colony forming 
cells were killed by the incubation with specific antisera against 
Rauscher virus. Apparently, the stem cells bear viral antigens, sug-
gesting that the stem cells are among the target cells of the virus. 
Besides, the leukaemic colony forming cells were shown to be less 
sensitive to normal rabbit serum than normal mouse colony forming 
cells. This might be an argument for a virus-induced cellular change 
which could be a step in the leukaemic transformation of the stem 
cell in Rauscher erythroblastosis. 
To account for the discrepancy of the normal differentiation of 
granulocytes and megakaryocytes and the leukaemic derailment of 
the erythroblasts which originate from the same stem cells, the fol-
lowing hypothesis was proposed: the viral oncogenes only cause 
leukaemic transformation when activated together with those host 
genes which instruct for erythropoiesis. Consequently, physiological 
regulator mechanisms influence leukaemic transformation, resulting 
in a hormone-dependency of the disease. A model for leukaemogene-
sis is proposed for Rauscher erythroblastosis in which a feed back 
regulation sustains the erythroblastic expansion. 
In lethally irradiated mice, restored by the injection of leukaemic 
spleen cells, splenomegaly and erythroblastic infiltration in the liver 
develop. Since leukaemic and normal haematopoiesis in these animals 
originate from stem cells which were present during the leukaemia, 
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the situation in the restored mouse is comparable to a chemothera-
peutically induced remission of human leukaemia. Therefore, the 
mouse restored in this way might be an appropriate model for (com-
plete) remission in acute human leukaemia. 
The spleen weight of lethally irradiated mice restored with leuk-
aemic spleen cells did not exceed I 000 mg, whereas the spleen 
weight in virus-infected normal mice may amount to 2 - 3000 mg! 
Moreover, the animals survived for I or 2 months after this weight 
had been attained. A deficient recruitment of bone marrow cells in 
irradiated mice might be among the factors causing the cessation of 
splenic growth. These restored mice are immunological cripples and 
die probably from opportunistic infections. 
Finally, some perspectives for the conception and the treatment 
of human leukaemia are discussed in the light of the presented data. 
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SAMENVATTING 
Het beschreven onderzoek had tot doe! het inzicht in de patho-
genese van leukaemieen te verdiepen. 
Verscheidene theorieen over het wezen van maligne ontaarding 
zijn te herleiden tot veranderingen in het genoom van de eel of in de 
expressie van bepaalde genen. De argumenten dat in vele gevallen een 
virus verantwoordelijk is stapelen zich op. Volgens sommigen is een 
"oncogeen" zelfs in aile lichaamscellen in het genoom ingebouwd en 
kan de expressie hlervan geluxeerd worden door ouderdom of door 
allerlei invloeden van buitenaf, zoals ioniserende straling, physische 
en chemische agentia. 
Zowel bij carcinomen als bij leukaemieen krijgt men de indruk, 
dat slechts een klein percentage van de cellen zich actief deelt en 
verantwoordelijk is voor de groei van de gehele tumor, resp. de 
leukaemische celpopulatie. Bij lymphoblasten-leukaemieen is aange-
toond dat inactieve blasten weer in mitose kunnen komen en aldus 
weer kunnen bijdragen tot de celvermeerdering. Daarnaast vermoedt 
men dat de leukaemische celpopulatie wordt gevoed door het stam-
celcompartiment. 
Het feit dat na effectieve chemotherapie een complete remissie 
kan optreden met normale bloedvorming, doet vermoeden dat er 
stamcellen tijdens de acute leukaemie onaangetast blijven en in gun-
stiger omstandigheden in staat zijn normale progenituur te krijgen. 
Tegenover de 'clonale' theorie, waarin verondersteld wordt dat de 
gehele leukaemische populatie uit een of hoogstens enkele leukae-
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mische stamcellen ontstaat, staat de exogene theorie, waarin aange-
nomen wordt dat de cellen die het stamcelcompartiment verlaten 
getransformeerd worden door een uitwendige oorzaak, b.v. een virus. 
In beide gevallen zou de meerderheid van de stamcellen normaal zijn. 
Een derde theorie pleit voor de leukaemische verandering van aile 
stamcellen. Een complete remissie zou slechts schijnbaar zijn: a! rij-
pen de bloedcellen uit tot - oppervlakkig beschouwd - normale 
eindstadia, in wezen zi.in het leukaemische cellen. Geavanceerde tech-
nieken zijn in staat subtiele verschillen ten opzichte van normale 
ce!len aan te tonen. 
Voor elk van de drie theorieen zijn vele steekhoudende argumen-
ten aan te voeren. Het directe bewijs was echter niet te leveren omdat 
de haematopoietische stamcel bij de mens tot voor kort slecht toe-
ganke!ijk was voor onderzoek en omdat men om trent de oorzaak van 
menselijke leukaemieen nog steeds in het duister tast. Daarom werd 
een experimenteel model gekozen voor het onderzoek van de pluri-
potente haematopoietische stamcel. Een door virus gei:nduceerde 
leukaemie bij muizen leek het meest geschikt. 
Door Rauscher werd in 1962 een virus gevonden dat in daarvoor 
gevoelige muizenstammen een woekering van rode bloedcellen ver-
oorzaakte, culminerend in een sterke vergroting van lever en milt, het 
verschijnen van onrijpe cellen in het perifere bloed en een vroegtijdi-
ge dood van de gei:nfecteerde dieren. Deze z.g. erythroblastose is 
vrijwel identiek aan de door Friend beschreven erythro-leukaemie en 
is wei vergeleken met de ziekte van Di Guglielmo bij de mens. 
Het natuurlijke verloop van deze erythroblastose werd vergeleken 
met de beschrijvingen die door andere onderzoekers werden gepubli-
ceerd. Bij BALB/ c muizen, besmet met Rauscher-virus werd een 
typische erythroblastose gezien zonder aanwijzingen voor woekering 
van lymphatische of myeloide elementen. Bij een andere muizenstam 
daarentegen - de C57BL muis - werden door hetzelfde virus zowel 
lymphatische als myeloide leukaemieen ge1nduceerd, hetgeen er op 
zou kunnen wijzen dat niet zozeer het virus alswel de gastheer het 
type van de leukaemie bepaalt. Vermindering van de dosis toegediend 
virus resulteerde in een uitstel van de miltvergroting, overigens trad 
een identiek ziektebeeld op. Bij te sterke verdunning (< I0-3, uit-
gaande van het onverdunde preparaat) konden geen tekenen van 
leukaemie worden waargenomen. Vermoedelijk is een zekere hoeveel-
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heid van het virus in het Iichaam van het gefnfecteerde dier nodig om 
tot ziekteverschijnselen te kunnen leiden. 
Bij de erythro blastose werden de belangrijkste veranderingen ge-
vonden in de milt. Werd de milt verwijderd v66r de infectie met het 
virus dan traden de grootste veranderingen op in de lever. Het virus 
bereikt zijn doe! echter ook wanneer lever en milt bestraald worden: 
door tijdens letale bestraling tijdelijk een achterpoot van de muizen 
af te schermen kon aannemelijk worden gemaakt dat het effect van 
virus-besmetting afhankelijk was van het aantal intacte beenmergcel-
len. 
Door middel van transplantatie van leukaemische miltcellen die in 
de gastheer herkenbaar waren aan een chromosomale merker, kon 
worden vastgesteld dat de leukaemische miltcellen niet autonoom 
groeiden. Dit maakte het waarschijnlijk, dat voor de handhaving en 
de uitbreiding van de leukaemische celpopulatie een constante recru-
tering van cellen uit een stamcel-compartiment noodzakelijk was. 
Gezien het voorafgaande zou het beenmerg hierin een belangrijke rol 
kunnen spelen. 
Bij muizen is een quantitatieve bepaling van het aantal stamcellen 
mogelijk met behulp van de miltkolonie-proef van Till & McCulloch. 
Haematopoietische stamcellen, ingespoten in letaal bestraalde mui-
zen, geven aanleiding tot de vorming van kolonies op het oppervlak 
van de milt. Iedere kolonie wordt gevormd door een eel; het aantal 
kolonies dat ontstaat uit een bepaalde hoeveelheid ingespoten cellen 
is een maat voor het aantal stamcellen in de ingespoten celsuspensie. 
De eenheid is de "kolonie-vormende eenheid", uitgedrukt in 
C F U I I o6 cellen. Deze techniek werd toegepast voor het bepalen 
van het aantal stamcellen in de milt van leukaemische muizen. Hierbij 
bleek, dat het aantal CFU's per I o6 miltcellen in het verloop van de 
incubatie-periode en ontwikkeling van de leukaemie gelijk bleef on-
danks de enorme groei van de milt in de zelfde periode. Het absolute 
aantal CFU's stijgt dus evenredig met het aantal miltcellen, d.w.z. tot 
20 a 30 maal de uitgangswaarde. 
Het vermogen tot differentiatie van deze stamcellen leek onge-
stoord, te oordelen naar de verdeling van de kolonies naar celtype. 
Bovendien bleek het mogelijk door intraveneuze injectie van leukae-
mische miltcellen de levensduur van letaal bestraalde muizen te ver-
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lengen. De stamcellen uit de leukaemische milten zijn dus in staat 
functionerende eindcellen te vormen. Rieruit zou men kunnen con-
cluderen dat tijdens deze virus-leukaemie de stamcellen normaal blij-
ven. 
Door specifieke, tegen het Rauscher-virus gerichte cytotoxische 
antilichamen bleken vrijwel aile kolonievormende cellen ge!nacti-
veerd te worden. Dit wijst op de aanwezigheid van virus-antigenen op 
het oppervlak van de stamcellen. De conclusie, dat het virus aangrijpt 
op zeer primitieve voorstadia van de haematopoiese lijkt derhalve 
gerechtvaardigd. 
De leukaemische CPU's waren in dezelfde proeven minder gevoe-
lig voor natuurlijke cytotoxische antilichamen, welke voorkomen in 
de gebruikte konijne-sera, dan de CPU's van normale muizen; blijk-
baar missen de besmette starncel!en bepaalde antigene determinan-
ten. Dit kan geduid worden als een uiting van de transformatie van de 
pluripotente stamcel. 
Remming van de erythropoiese door bloedtransfusies remt ook de 
ontwikkeling van de erythroblastose, terwijl stimulering van de ery-
thropoiese d.m.v. exogeen erythropoietine de erythroblastose juist 
bevordert. Dit is door verscheidene auteurs aangevoerd als argument 
voor de hypothese dat een erythroblastose zou ontstaan door de 
transformatie van de z.g. erythropoietine-gevoelige voorloper van de 
erythroide reeks, die aangemerkt wordt als de "target cell" van 
Rauscher- en Friend-virus. Ret feit, dat verschillende rijpingsstadia 
van de rode celreeks besmet worden door het virus wijst erop, dat het 
virus zich niet beperkt tot een "target cell". Niet aile besmette cellen 
ontaarden. Voor de expressie van de maligne ziekte is het blijkbaar 
noodzakelijk dat de eel zich in een bepaalde richting differentieert. 
In het geval van de erythroblastose is het de erythroide differentia tie 
die het oncogeen de gelegenheid biedt de eel te transformeren. Prik-
kels tot differentia tie in de richting van myelopoiese of thrombopoie-
se Iaten in de BALB/c muis het oncogeen ongemoeid en leiden tot de 
vorming van normale leukocyten en thrombocyten. 
Ter verklaring van deze discrepantie werd de volgende hypothese 
opgesteld. Ret virus, of een DNA-copie ervan, veroorzaakt slechts 
maligne ontaarding wanneer het geactiveerd wordt tesamen met 
genen, die een rol spelen bij de differentia tie van de rode celreeks. Op 
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analoge wijze zouden tumoren van endocriene organen beinvloed 
kunnen worden door hormonale prikkels. Wellicht bepaalt de plaats 
waar een provirus wordt geincorporeerd in de DNA-keten van de 
gastheercel het specifieke effect. 
De muizen, die herstellen van letale bestraling door de injectie van 
leukaemische stamcellen, krijgen eveneens leukaemie. Merkwaardiger-
wijs stijgt hun miltgewicht niet boven 800 il. 1000 mg. Deze dieren 
sterven pas na 2 il. 3 maanden aan intercurrente infecties, vermoede-
lijk doordat het immunologische apparaat zich niet herstelt van de 
schade door de bestraling. lnmiddels blijkt de haematocriet een stij-
ging te vertonen van ± 30 tot ± 40%. Ondanks de aanwezigheid van 
virus rijpt een groat aantal erythroblasten uit tot functionerende 
eindcellen. Om dit te verklaren wordt een vergelijking getrokken met 
de spontane regressie, die is waargenomen bij sommige muizen-
leukaemieen en met het phenomeen van de reversibele transformatie. 
Getracht wordt dit te verenigen met de hypothese dat sommige onco-
genen uitsluitend werkzaam zijn wanneer ze tesamen met bepaalde 
gastheer-genen geactiveerd worden, hetzij onder invloed van dezelfde 
humorale substantie (erythropoietine?) hetzij door synergistische 
werking van beider producten. 
Wanneer het geoorloofd is de conclusie van dit dier-model te 
projecteren op bepaalde vormen van menselijke leukaemieen, kan in 
de eerste plaats gesteld worden dat er vele pun ten van overeenkomst 
zijn tussen de bestudeerde leukaemie bij de muis en verschlllende 
vormen van leukaemie bij de mens. Er is weinig in tegenspraak met 
de mogelijkheid dat leukaemie bij de mens door een overeenkomstige 
fout in het genoom zou kunnen worden veroorzaakt, eventueel door 
een virus. 
De aanwijzingen die werden gevonden voor een constante recrute-
ring van cellen uit een stamcelcompartiment komt overeen met de 
opvatting van Gavosto over de blastenleukaemie. Aangezien de moge-
lijkheid blijkt te bestaan dat de haematopoietische cellen a! in een 
zeer vroeg stadium besmet worden, pleit de afwezigheid van infec-
tieus virus tijdens de ziekte niet tegen een virale aetiologie. Een com-
plete remissie zou slechts schljnbaar zijn, zoals voorgesteld door de 
"Leukaemia-minor"-theorie van Killmann. Deze zou mogelijk ge-
maakt worden door een onderdrukking van het oncogeen, dat echter 
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in de cellen aanwezig blijft. 
De letaal bestraalde muis, welke in Ieven wordt gehouden door de 
transplantatie van leukaemische cellen !ijkt een goed model voor de 
bestudering van een complete remissie, zoals bij een menselijke 
leukaemie wei eens geinduceerd kan worden met krachtige chemo-
therapie. Waarschijn!ijk zijn subtielere behandelingsmethoden nodig 
om een derge!ijke complete remissie ad libitum te verlengen. Mis-
schien opent het inzicht dat bepaalde vormen van !eukaemie hormo-
naal beinvloedbaar zijn nieuwe perspectieven. 
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